The QualityStocks Daily Thursday, May 2nd, 2024

Today's Top 3 Investment Newsletters

360 Wall Street(EBS) $3.3000 +70.98%

Schaeffer's(ASPN) $23.8500 +56.70%

QualityStocks(NUWE) $0.2060 +54.89%

The QualityStocks Daily Stock List

Artificial Intelligence Technology Solutions (AITX)

QualityStocks, MarketClub Analysis, The Street Report, Investors Alley and InvestorPlace reported earlier on Artificial Intelligence Technology Solutions (AITX), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Artificial Intelligence Technology Solutions Inc. (OTC: AITX) is focused on delivering robotic and artificial intelligence solutions for monitoring, security and operational needs. The company’s AI technologies are supported by custom cloud and software services and paired with multi-use hardware, which helps to intelligently integrate and automate operational, concierge and security tasks.

The firm has its headquarters in Reno, Nevada and was founded by John B. Crawford in 2010, on March 25. Before changing its name in August 2018 to Artificial Intelligence Technology Solutions Inc., the firm was known as On The Move Systems Corp. The company serves consumers in the U.S. and in particular, automobile fleet administrators and vehicle dealerships.

The company operates through its wholly-owned subsidiaries, one of which is Robotic Assistance Devices Inc. The subsidiary develops unique technology, specifically; mobileware, cloudware, software and hardware, which are used in the development of powerful tools like RADGuard, RADPMC and RADSOC as well as to improve performance in companies.

The firm is also engaged in the provision of mobile electronic services and offers after-market video, audio and electronic upgrades for boats, recreational vehicles and automobiles.

The company recently entered into an agreement with EAGL Technology Inc. for the provision of the latter firm’s gunshot detection system in all present and future RAD devices. The integration of EAGL solutions into the innovative products will not only make the products more popular but also expand their reach into the markets they serve, which will be good for investments as well as the firm’s stock.

Artificial Intelligence Technology Solutions (AITX), closed Thursday's trading session at $0.0078, up 56%, on 364,896,587 volume. The average volume for the last 3 months is 2.594M and the stock's 52-week low/high is $0.0019/$0.0146.

Nuwellis Inc. (NUWE)

QualityStocks, The Stock Dork, StockEarnings, MarketClub Analysis, MarketBeat and BUYINS.NET reported earlier on Nuwellis Inc. (NUWE), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Nuwellis Inc. (NASDAQ: NUWE) is a medical device firm that is focused on providing medical devices that help treat fluid overload, heart failure and other cardiac ailments.

The firm has its headquarters in Eden Prairie, Minnesota and was incorporated in November 1999 by William S. Peters and Crispin Mash. Prior to its name change in April 2021, the firm was known as CHF Solutions Inc. It operates in the healthcare sector, under the medical equipment and devices sub-industry.

The company’s objective is to transform fluid management care. Its partnerships are focused on trying to better understand patients’ priorities and their needs. The company aims to improve the quality of life of its patients.

The enterprise operates through the coronary disease and cardiac products segment. Its products include the SmartFlow, Aquadex and Aquadex Flex Flow systems. These systems have been developed for treating patients who suffer from fluid overload and have failed diuretics. The enterprise’s Aquadex FlexFlow system is made up of a catheter, disposable blood set and a console. It sells its products directly to clinics and hospitals via its direct salesforce in the U.S., as well as via independent specialty distributors mainly in the United Kingdom, Thailand, Switzerland, Spain, Singapore, Palestine, Italy, Israel, India, Hong Kong, Greece, Germany, Brunei, Brazil and Austria.

The company was recently awarded a national contract by Premier Inc., which will facilitate the expansion of access to the firm’s Aquadex product. This move not only benefits the patients who will be able to access the product easily but also bring in more investors into the firm, which will boost its growth.

Nuwellis Inc. (NUWE), closed Thursday's trading session at $0.206, up 54.8872%, on 72,293,040 volume. The average volume for the last 3 months is 13.093M and the stock's 52-week low/high is $0.125/$4.84.

BlackStar Enterprise Group, Inc. (BEGI)

QualityStocks, MarketClub Analysis, Small Cap Firm, HotOTC, OTCtipReporter, PoliticsAndMyPortfolio, Penny Pick Finders, PennyStockProphet, Buzz Stocks, PennyStockScholar, Profitable Trader Authority, StockHideout, StockOnion, Wall Street Mover, Wealth Insider Alert, StockStreetWire, StockWireNews, MicroCapDaily, TopPennyStockMovers, Leading Penny Stocks, Insider Financial, Fierce Analyst and Planet Penny Stocks reported earlier on BlackStar Enterprise Group, Inc. (BEGI), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

BlackStar Enterprise Group, Inc. is a specialized merchant banking firm listed on the OTC Markets Group’s OTCQB. The Company facilitates joint venture (JV) capital to early stage revenue companies. Its emphasis is on blockchain technology and it intends to gain exposure to the blockchain ecosystem via targeted JVs in the sector. The main concentration is on the distributed ledger security features and peer-to-peer (P2P) global equity trading arena.

Established in 2007, BlackStar Enterprise Group is headquartered in Boulder, Colorado. The Company previously went by the name BlackStar Energy Group, Inc. It changed its name to BlackStar Enterprise Group, Inc. in September of 2016.

The Company’s intention is to take advantage of its experience in the traditional world of public finance, including securities, options, registrations and SEC compliance, into working with select organizations supporting the development and implementation of new technologies in the crypto currency world. In addition, BlackStar is becoming an advocate and supporter of P2P equity trading on a distributed decentralized ledger that provides investment exposure to the fast growing blockchain ecosystems.

BlackStar Enterprise Group acts as a merchant bank providing access to capital for companies involved in crypto-equities with P2P trading. The Company will facilitate these companies, by way of majority controlled JVs with its subsidiary Crypto Equity Management Corp. This offers it shareholders entry into the ground-breaking crypto equity/cybersecurity space.

BlackStar Enterprise Group, Inc. (BEGI), closed Thursday's trading session at $0.0034, up 30.7692%, on 37,563,787 volume. The average volume for the last 3 months is 65.928M and the stock's 52-week low/high is $0.0001/$0.012797.

Jaguar Health (JAGX)

QualityStocks, MarketBeat, BUYINS.NET, StockMarketWatch, StreetInsider, InvestorPlace, The Online Investor, MarketClub Analysis, StocksEarning, StockRockandRoll, Schaeffer's, PennyStockLocks, Penny Stock 101, 360wallstreet, DreamTeamNetwork, 247 Market News, Promotion Stock Secrets, Wealth Insider Alert, Stock Beast, The Stock Dork, Trades Of The Day and PoliticsAndMyPortfolio reported earlier on Jaguar Health (JAGX), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Jaguar Health Inc. (NASDAQ: JAGX) (FRA: 1JA2) is a commercial-stage pharmaceuticals firm that is focused on developing and commercializing gastrointestinal products for animals and human prescription use and non-prescription gastrointestinal animal products.

Jaguar Health has its headquarters in San Francisco, California and serves the human and animal health markets across the globe. The firm was established on June 6, 2013 by Lisa A. Conte.

Through its Napo Pharmaceuticals Inc. subsidiary, Jaguar Health Inc. develops and commercializes proprietary human gastrointestinal products. This is in addition to operating through 2 segments: Animal health segment and Human health segment. The former segment commercializes non-prescription and prescription products for production and companion animals while the latter segment develops human products and advertises one of the firm’s products called Mytesi which is used to provide symptomatic relief of non-infectious diarrhea in adults on ARV therapy for HIV/AIDS.

Jaguar Health Inc.’s human products include a crofelemer formulation which is currently undergoing a phase 2 clinical trial for the treatment of irritable bowel, functional/idiopathic diarrhea, congenital diarrheal disorder and short bowel syndrome; crofelemer, which is in its phase 3 clinical trials for supportive care for inflammatory bowel disease and treatment of diarrhea associated with cancer therapy. The firm’s animal products include Neonorm Foal and Neonorm Calf, as well as a non-prescription product for gut health in equine athletes known as Equilevia and an animal prescription drug candidate indicated for the treatment of diarrhea in dogs induced by chemotherapy, called Canalevia.

Jaguar Health Inc. recently incorporated its Napo EU subsidiary in anticipation of its merger with Italian Dragon SPAC, which will broaden the firm’s consumer base overseas and boost growth. The subsidiary will help address the increasing burden of inflammatory diarrhea that has been linked to long-hauler syndrome in the post-coronavirus patient population over in Europe.

Jaguar Health (JAGX), closed Thursday's trading session at $0.2932, up 30.3111%, on 184,272,903 volume. The average volume for the last 3 months is 1.967M and the stock's 52-week low/high is $0.0512/$1.22.

Origin Materials Inc. (ORGN)

SmarTrend Newsletters, MarketBeat, QualityStocks and InsiderTrades reported earlier on Origin Materials Inc. (ORGN), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Origin Materials Inc. (NASDAQ: ORGN) is a carbon negative materials firm that has found a way to transform carbon into useful materials.

The firm has its headquarters in West Sacramento, California and was incorporated in 2008. The firm serves consumers around the globe.

The company is focused on accelerating the world’s transition to sustainable materials. It is party to an alliance with Danone and Nestle Waters, which entails the commercialization of its first plant-based PET plastic with a low carbon footprint. It believes that making products in the future will present an opportunity to capture carbon in durable goods. The company is developing and commercializing its core technology, which will help revolutionize the production of an extensive range of end products.

Over the last decade, the enterprise has developed a platform that captures carbon and eliminates the need for fossil resources, as it turns sustainable wood residues into materials which are carbon negative. It enables the transition to sustainable materials by replacing materials which are petroleum-based with decarbonized products like soil amendments, adhesives, tires, carpeting, car parts, plastics, textiles, clothing and food and beverage packaging. Its technology also converts sustainable feedstock like corrugated cardboard, wood waste, agricultural waste and sustainably harvested wood, into products and materials which are manufactured from fossil feedstock, like natural gas and petroleum.

The company recently announced a new partnership with Drive+ which will allow it to work with Drive Sustainability Partners on carbon neutrality, raw material standards and other crucial sustainability topics in the automotive supply chain. This move is a step forward in the company’s mission to facilitate global transition to the use of sustainable materials and will afford the company more opportunities for growth and investment.

Origin Materials Inc. (ORGN), closed Thursday's trading session at $0.9983, up 23.6591%, on 4,181,395 volume. The average volume for the last 3 months is 47,220 and the stock's 52-week low/high is $0.4422/$5.04.

Nano One Materials (NNOMF)

TradersPro and QualityStocks reported earlier on Nano One Materials (NNOMF), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Nano One Materials Corp (OTC: NNOMF) (TSE: NANO) (LON: 0T6N) (FRA: LBMB) is a technology firm that is focused on the production of cathode active materials for lithium-ion battery applications in electric vehicles, energy storage systems and consumer electronics applications.

The firm has its headquarters in Burnaby, Canada and was incorporated in 1987, on November 5th by John E. Lando and Dan Blondal. It operates as part of the specialty chemicals industry, under the basic materials sector. The firm serves consumers across the globe.

The company focuses on building a portfolio of intellectual property and technology know-how for applications in markets that include energy storage, specialty ceramics, pharmaceutical, semiconductors, aerospace, dental, catalysts, and communications. It offers lithium iron phosphate, nickel-manganese-cobalt oxide, lithium nickel manganese oxide, and other cathode materials.

The enterprise deploys a three-stage process using industry standard equipment which is being engineered for high volume production and rapid commercialization. Its One-Pot process, its coated nanocrystal materials, and its Metal-to Cathode Active Material (M2CAM) technologies address the needs and supply chain constraints while reducing costs and carbon footprint. It offers coated nanocrystal technology that addresses a battery trade-off between energy density and durability. Its M2CAM technology (metals to cathode active materials) is focused on cost, waste, and the carbon footprint in the lithium-ion battery supply chain. Its One-Pot Process forms single crystal cathode powders and protective coatings, which is being adapted for M2CAM, enabling these materials to be made directly from nickel, manganese, and cobalt metal powder feedstocks.

The firm recently entered into a joint development agreement with Our Next Energy to produce and supply lithium iron phosphate cathode active materials. This move will not only bring in additional revenues into the firm but also open it up to new growth and investment opportunities.

Nano One Materials (NNOMF), closed Thursday's trading session at $1.55, up 22.7334%, on 225,184 volume. The average volume for the last 3 months is 27,874 and the stock's 52-week low/high is $1.12/$2.70.

Air Industries (AIRI)

TaglichBrothers, The Online Investor, TraderPower, StockMarketWatch, StreetInsider, MarketBeat, TradersPro, QualityStocks, Zacks, The Street, Profit Confidential, Money Morning, Marketbeat.com, InvestorPlace and Greenbackers reported earlier on Air Industries (AIRI), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Air Industries Group (NYSE American: AIRI) (FRA: YH1N) is an aerospace and defense firm that is focused on designing, manufacturing and selling structural parts and assemblies for defense contractors in the aerospace industry.

The firm has its headquarters in Bay Shore, New York and was incorporated in 1979. It operates as part of the aerospace product and parts manufacturing industry and has eight companies in its corporate family. The firm operates through its wholly owned subsidiaries, which include Sterling Engineering Corp, Nassau Tool Works Inc. and Air Industries Machining Corp.

The company serves and operates through the Turbine engine components and the Complex machining segments. The former segment is involved in the provision of turn-key welded solutions and services for ground-power turbines and jet engines. On the other hand, the latter segment is engaged in the manufacture of critical machines components and assemblies that focus on flight safety, which includes jet engines, throttle quadrants, flight controls, engine mounts, arresting gear and landing gear, which are fabricated from hard metals like 300M, titanium and Inconel.

The enterprise’s jet engine components are used on the U.S. Navy F-16 and F-15 fighter aircrafts as well as the Airbus A-380 and A-330. Its products are also deployed on various commercial and military aircrafts, including Boeing’s 777, Northrop Grumman E2 Hawkeye, Lockheed Martin F-35 Joint Strike Fighter and the Sikorsky UH-60 Black Hawk.

The firm recently announced its latest financial results, which show increases in gross profit, net sales and operating income. It is now focused on enhancing its capabilities and entering into new agreements, having recently announced a 3-year agreement for the F-35 Joint Strike Fighter Aircraft worth no less than $12 million.

Air Industries (AIRI), closed Thursday's trading session at $6.68, up 15.1724%, on 118,153 volume. The average volume for the last 3 months is 9.6M and the stock's 52-week low/high is $2.60/$7.60.

Greene Concepts (INKW)

QualityStocks, PennyTrader, Penny Picks, HotOTC, Damn Good Penny Picks, Wall Street Mover, PREPUMP STOCKS, Penny Stock Newsletter, MicroCapDaily, MegaPennyStocks and MarketClub Analysis reported earlier on Greene Concepts (INKW), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Greene Concepts, Inc. (OTC: INKW) manages a beverage and bottling firm in Marion, North Carolina through Mammoth Ventures Inc., its wholly-owned subsidiary.

The company is based in Clovis, California and was founded in 1952, on August 18th by Leonard M. Greene. Its product line is made up of enhanced athletic drinks, beverage offerings, artesian and spring water as well as ketogenic and CBD-infused beverages. The company is focused on delivering water to its consumers directly.

Its Marion plant is a 60,000 ft2 bottling and beverage facility that is found within the Pisgah National Forest boundaries. The plant’s water source is a combination of 7 artesian and spring wells that are fed from a natural aquifer found in the Pisgah forest. Mammoth Ventures is also a 3rd party bottler and producer of ‘white label’ water and beverage products. These services are offered to clients that would like to market their own product formulations, labeling and brand name while outsourcing the bottling and production of their products to Mammoth. Through its Water Club Inc. subsidiary, the company is pursuing subscription-based delivery of scientifically formulated beverages and water directly to the consumer’s markets and homes.

The firm recently hired an auditing company to audit its financials, in preparation for an up list to the NASDAQ. This could not only lead to a change in its stock symbol but also attract more investors, which will boost both the firm’s share prices as well as its growth.

Greene Concepts (INKW), closed Thursday's trading session at $0.0035, up 14.7917%, on 28,822,404 volume. The average volume for the last 3 months is 176,027 and the stock's 52-week low/high is $0.00164/$0.0067.

OLB Group (OLB)

RedChip, QualityStocks, MarketClub Analysis, StockWireNews, Weekly Newsletter, StockStreetWire, Small Cap Firm, Schaeffer's, MarketBeat, InsiderTrades and Fierce Analyst reported earlier on OLB Group (OLB), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

The OLB Group Inc. (NASDAQ: OLB) is a FinTech and payment facilitator firm that is focused on providing payment facilitator verticals and integrated business solutions.

The firm has its headquarters in New York and was incorporated in 2004, on November 18th by Ronny Yakov. It operates as part of the software publisher’s industry and primarily serves consumers in the State of New York as well as the entire United States.

The company is focused on offering merchant services and products like support for crowd funding and other capital raising initiatives and financial transaction processing services, through different online platforms. It mainly operates through OLBit Inc. as well as through the CrowdPay.us Inc., OmniSoft.io Inc. and eVance Inc. subsidiaries. OLBit is involved in cryptocurrency-related lending and transactional business. The company mainly serves single store retailers, retailers and manufacturers.

The enterprise’s products include a cloud-based omni-channel software dubbed ShopFast; a white label capital raising platform known as CrowdPay.us; a payment gateway and virtual terminal with business management tools dubbed SecurePay; and a payment processing solution known as eVance. In addition to this, the enterprise provides a cloud-based business management platform which offers turnkey solutions for merchants and allows them to manage and build their retail businesses, known as OmniSoft. The enterprise also offers consulting and e-commerce development services.

The company recently announced its second quarter financial results, which show increases in revenue and the transactions processed. It is currently focused on helping merchants and their businesses leverage the fast expanding scope of payment acceptance technologies in-store, mobile and online.

OLB Group (OLB), closed Thursday's trading session at $0.4896, up 12.539%, on 2,899,184 volume. The average volume for the last 3 months is 18,425 and the stock's 52-week low/high is $0.2839/$1.17.

Jacksam Corp. (JKSM)

QualityStocks and CFN Media Group reported earlier on Jacksam Corp. (JKSM), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Jacksam Corp. (OTC: JKSM) is a technology firm focused on the development and commercialization of products of vaporizer cartridge filling and capping, pre-roll filling, and other automation systems using its open source technology platform.

The firm has its headquarters in Costa Mesa, California and was incorporated in 1989, on September 21st by Daniel Davis. It operates as part of the specialty industrial machinery industry, under the industrials sector. The firm serves consumers primarily in the United States.

The company does its business under Convectium. Its goal is to help improve efficiency post-harvest & post extraction for players in the cannabis industry. Its automation experts can also help increase efficiency on the flower side of the business. The company derives revenues from the sale of machines and non-machine products.

Jacksam’s product offerings include 710 Captain cartridge capping machines, 710 Shark cartridge filling machines, C-Cell cartridges, PreRoll-ER pre-roll and cone filling machines. Its PreRoll-ER machines are capable of rolling up to 2,000 cones per hour. The enterprise markets and sells its products to large and small-scale processors and growers, multi-state operators, medical and recreational dispensaries, and distributors through a direct sales force, independent sales representatives, strategic partners' sales force, and a referral network, as well as its website. It serves the medical and recreational cannabis, hemp, and CBD segments of the e-cigarette, vaporizer, and pre-roll markets.

The firm is focused on growing as it invests in its products and intellectual property. This may positively influence investments into the firm as well as its overall growth, in addition to creating value for its shareholders.

Jacksam Corp. (JKSM), closed Thursday's trading session at $0.01024, even for the day. The average volume for the last 3 months is 6.116M and the stock's 52-week low/high is $0.0056/$0.0273.

SNDL Inc. (SNDL)

Schaeffer's, InvestorPlace, StockEarnings, StocksEarning, QualityStocks, MarketBeat, Trades Of The Day, Daily Trade Alert, BUYINS.NET, Kiplinger Today, The Street, StreetInsider, The Online Investor, FreeRealTime, Early Bird, CNBC Breaking News, Investopedia, MarketClub Analysis, StockMarketWatch and MarketClub reported earlier on SNDL Inc. (SNDL), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

According to a new survey, the majority of Americans believe that marijuana is less detrimental to health than tobacco and alcohol. According to the YouGov poll, 64% of participants believe that regular alcohol consumption is riskier than marijuana use, and 63% believe that regular tobacco use is also riskier. The survey conducted from April 5–8, 2024, involved 1,148 adults.

Contrastingly, only a small fraction — 14% — believes that cannabis usage poses a greater threat than regular alcohol consumption. Additionally, 16% of participants stated that marijuana is more detrimental than tobacco. In total, 53% of those surveyed indicated that both tobacco and alcohol are more detrimental to health than cannabis.

These findings align with other recent surveys, such as one conducted by Gallup, which revealed that Americans generally perceive cannabis as less detrimental than cigarettes, alcohol and vaping. Moreover, the survey noted that marijuana use has overtaken cigarette consumption in the United States while vaping is currently behind both.

Similarly, a JAMA poll published last year indicated a shift in public perception, with more people considering smoking cannabis or secondhand marijuana smoke exposure as safer compared to tobacco smoke.

The YouGov poll also revealed that a significant majority of Americans — 62% — support marijuana legalization. This sentiment cuts across political affiliations, with 46% of Republicans, 67% of independents and 71% of Democrats expressing support for legalization.

Regarding usage patterns, 56% admitted to trying cannabis in their lifetime, with 24% reporting consumption within the past year and 17% within the last 30 days. Among those who consumed marijuana in the past year, 24% used it several times daily, 11% used it once daily and 20% used it occasionally.

According to the survey, smoking bud or flower was the most popular (61%) form of use among those who have tried cannabis or CBD. Furthermore, if cannabis were to be legalized countrywide, 67% of nonusers stated that they would keep abstaining. Another 14% expressed uncertainty about trying it, while 6% said they likely would, and 2% said they certainly would.

Meanwhile, another recent survey revealed that more than one-half of the adult population was surprised by the fact that cannabis remains federally illegal in the United States.

Furthermore, a Pew Research Center survey found that 90% of Americans support the legalization of cannabis for either medical or recreational purposes. Most respondents stated that legalization enhances equity in the criminal justice system and helps the local economy.

As perceptions toward marijuana keep changing, cannabis companies such as SNDL Inc. (NASDAQ: SNDL) could see their clientele growing in the different markets in which they have operations.

SNDL Inc. (SNDL), closed Thursday's trading session at $2.27, up 2.2523%, on 4,765,148 volume. The average volume for the last 3 months is 16.101M and the stock's 52-week low/high is $1.25/$2.67.

Alibaba Group Holding Ltd. (BABA)

InvestorPlace, The Street, Kiplinger Today, Schaeffer's, MarketClub Analysis, Money Morning, Zacks, StreetInsider, Trades Of The Day, Daily Trade Alert, Marketbeat, Market Intelligence Center Alert, StocksEarning, Investopedia, The Online Investor, Wealth Insider Alert, StreetAuthority Daily, ProfitableTrading, CustomerService, Marketbeat.com, TopStockAnalysts, Early Bird, Louis Navellier, Uncommon Wisdom, GorillaTrades, CNBC Breaking News, Cabot Wealth, Top Pros' Top Picks, Profit Confidential, StockEarnings, TipRanks, The Wealth Report, AllPennyStocks, Options Elite, Total Wealth, Investors Alley, Money and Markets, Street Insider, Daily Profit, INO.com Market Report, Wyatt Investment Research, The Street Report, Barchart, SmallCapVoice, Investing Daily, QualityStocks, StrategicTechInvestor, Market Intelligence Center, Insider Wealth Alert, Power Profit Trades, Average Joe Options, Daily Wealth, Trade of the Week, Investing Signal, INO Market Report, MarketTamer, WStreet Market Commentary, Wealth Daily, Wall Street Daily, BUYINS.NET, Trader Prep, Trading Concepts, The Best Newsletters, Short Term Wealth, MarketWatch, 24/7 Trader, Inside Investing Daily, Dynamic Wealth Report, Rick Saddler, InvestmentHouse, Visual Capitalist, TheOptionSpecialist, FreeRealTime, Energy and Capital, Investing Lab, Investment U, Investing Futures, MarketArmor.com, The Weekly Options Trader, OptionAlarm News, ChineseWire, Wealthpire Inc., SureMoney, Agora Financial, Daily Dividends, InvestorsHQ, Financial Freedom Post, Equities.com, 24-7 Stock Alert, wyatt research newsletter, Energy & Resources Digest, Atomic Pennies, Eagle Financial Publications, Beat The Street, Dividend Opportunities, Direction Alerts, wealthmintrplus, Wallstreet Journal, Weekly Wizards, The Growth Stock Wire, Navellier Growth, Rockwell Trading, Shah's Insights & Indictments, SmallCapNetwork, Stock Gumshoe, StockMarketWatch, Summa Money, Market Authority, Liberty Through Wealth, Kiplinger’s Weekly Update, Terry's Tips, Inside Trading, InvestorsObserver Team, Goldman Small Cap Research, InvestorGuide, Investor Guide, The Night Owl, Investment House, Investiv, The Stock Dork, Profits Run, The Trading Report, MarketDeal, TheoTrade, Hit and Run Candle Sticks, Greenbackers and Jim Cramer reported earlier on Alibaba Group Holding Ltd. (BABA), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Chinese e-commerce conglomerate Alibaba Group Holding Ltd. (NYSE: BABA) plans to achieve carbon neutrality in its operations by the end of the decade by adopting sustainability practices and cutting carbon emissions across the entirety of its digital ecosystem. With national and international policies pushing corporations toward increased sustainability, Alibaba is poised to meet its carbon targets through a variety of sustainability initiatives in China.

The company is now supporting efforts to increase sustainability among its employees, consumers and merchants across China. This includes an early 2024 trial that involved more than 27,000 students saving around two tons of takeaway lunchboxes daily from the dump and facilitating the recycling of a majority of the waste (70%). Alibaba senior vice president Xiao Shuixian says that the e-commerce giant will team up with more ecological institutions and partners to advance its exploration of renewables and achieve its carbon neutrality goals.

Alibaba’s Xixi Park campus in Hangzhou is the largest office community in the country to gain an LEED International Platinum certification from LEED, a globally recognized system of third-party certifications that measures building design and construction sustainability. The system is currently implemented in 285 regions and countries worldwide. LEED North Asia VP Wang Jing says he is “very happy” that the LEED standard can aid Alibaba and other internet technology companies in China achieve their carbon neutrality plans.

The Xixi Park campus saved more than 2,866 tons of C02 in 2022 by incorporating various energy-saving measures into its operations. Alibaba employees at the campus can self-adjust air conditioning temperature and lighting brightness at their workstations with a single click. Furthermore, they have control over their office equipment and can turn it on and off of their own volition.

The Alibaba Cloud Campus has also incorporated similar sustainability features and now sources nearly 70% of its water from recycled rainwater. Solar panels covering many of the buildings contribute to the cloud campus drawing 40% of its energy needs from renewables and putting Alibaba on track to achieving its carbon neutrality plans.

Alibaba subsidiary and e-commerce market Taobao has also invested in a program first conceptualized by a lone entrepreneur that has seen the marketplace plant more than 10,000 trees in the slowly expanding Tengri Desert. After a young entrepreneur took over an abandoned post office close to the desert and retrofitted it into a Taobao shop planting trees on customers’ behalf, thousands of trees have been planted in the surrounding area. With the Tengri Desert expanding year by year, the planted forest’s roots will be crucial to arrest desertification in China.

Alibaba Group Holding Ltd. (BABA), closed Thursday's trading session at $80.33, up 6.3833%, on 36,663,857 volume. The average volume for the last 3 months is 2.136M and the stock's 52-week low/high is $66.63/$102.50.

The QualityStocks Company Corner

Longeveron Inc. (NASDAQ: LGVN)

The QualityStocks Daily Newsletter would like to spotlight Longeveron Inc. (NASDAQ: LGVN) .

Longeveron (NASDAQ: LGVN), a clinical-stage biotechnology company developing cellular therapies for life-threatening and chronic aging-related conditions such as hypoplastic left heart syndrome ("HLHS"), Alzheimer's disease and Aging-Related Frailty, will be releasing its first-quarter 2024 financial results this month. The company announced that it will release the report, along with a business update, on May 14, 2024, after the U.S. markets close. The company has also scheduled a conference call and webcast to discuss the release; the call will begin at 5 p.m. ET, also on May 14. Those wishing to access the call can dial 877-407-0789 and use the conference ID 13745868. An archived version of the call will be available on the company's website.

To access the webcast, visit https://ibn.fm/AIEoH

To view the full press release, visit https://ibn.fm/XkbWZ

Longeveron Inc. (NASDAQ: LGVN) is a clinical-stage biotechnology company developing regenerative medicines to address unmet medical needs for specific aging-related and life-threatening conditions. The Company’s research and therapies are aimed at improving the outcome of infants born with a life-threatening heart condition, as well as improving the healthspan for the aging population – the number of years a person is expected to live in relatively good health, free of chronic disease and disabilities of aging, with function and ability to perform activities of daily living.

Longeveron is involved in clinical trials in the following indications: Hypoplastic left heart syndrome (HLHS), Alzheimer’s disease, and Aging-related Frailty.

The Company’s philosophy revolves around the idea that regenerative medicine may hold the potential to improve certain rare medical conditions and contribute to healthy aging. While there has been a remarkable rise in life expectancy over the last century due to medical and public health advancements, this increase in longevity has not been paralleled by the number of years a person is expected to live in relatively good health, free of chronic disease and disabilities of aging.

Longeveron’s lead investigational product is Lomecel-B™, an allogeneic Medicinal Signaling Cell therapy product isolated from the bone marrow of young, healthy adult donors. As humans age, they experience a decrease in immune system function, a decline in blood vessel functioning, chronic inflammation, and other issues. Clinical data has suggested that Lomecel-B™ may address these conditions through multiple mechanisms of action (MOA) that simultaneously target key aging-related processes.

The Company is headquartered in Miami, Florida.

Lomecel-B™

Lomecel-B™ is being evaluated in multiple clinical trials for aging-related chronic diseases and other life-threatening conditions under U.S. FDA-approved Investigational New Drug applications. Lomecel-B™ has multiple potential mechanisms of action encompassing pro-vascular, pro-regenerative, anti-inflammatory, and tissue repair and healing effects with broad potential applications across a spectrum of disease areas.

The drug is made from special living cells called Medicinal Signaling Cells (MSCs) that are isolated from fresh bone marrow tissue that has been donated by adult donors aged 18 to 45. Once the MSCs have been isolated from the fresh bone marrow through a careful selection process, the cells are culture-expanded (allowed to replicate under controlled laboratory conditions) into the billions using specialized techniques and processes. After a specific number of expansion cycles, called “passages,” the cells are harvested, separated into specific doses (e.g., 50 million cells), and cryopreserved until future use.

These cells have been shown to have characteristics that allow them to be transplanted from a donor to host without triggering a harmful immune response in the recipient, and they can be administered on an outpatient basis in as little as 40 minutes after thawing. Because of these characteristics, Lomecel-B™ is considered an “off-the-shelf” product.

In some trials, such as for Alzheimer’s disease and Aging-related Frailty, Lomecel-B™ is administered via peripheral intravenous infusion, while, in the Company’s HLHS trial, Lomecel-B™ is administered via direct injection into the heart tissue.

Market Opportunity

Longeveron estimates the potential market size for Lomecel-B™ in the treatment of HLHS to be up to $1 billion annually, globally.

U.S. patients suffering from Aging-related Frailty are estimated using U.S. Census Bureau statistics to be approximately 8.1 million. That population potentially represents a market for Lomecel-B™ of between $4 billion and $8 billion globally per year, according to Company estimates.

Additionally, the Alzheimer’s Association puts the number of Americans with that disease at 5.1 million, highlighting another potentially addressable market for Lomecel-B™, that’s worth $5 billion to $10 billion annually.

Management Team

Wa’el Hashad is CEO of Longeveron. He has more than 35 years of experience in the pharmaceutical and biotech industries. He has launched several successful brands in the U.S. and worldwide markets. Prior to joining Longeveron, he was president and CEO of Avanir Pharmaceuticals. Before Avanir, he was the chief commercial officer of Seres Therapeutics. He also has held senior leadership positions at Amgen, Boehringer Ingelheim, and Eli Lilly and Company. He holds a bachelor’s degree in pharmacy from Cairo University and an MBA from the University of Akron.

Joshua M. Hare, M.D., FACC, FAHA, is Co-Founder, Chief Science Officer and Chairman of Longeveron. He is a double board-certified cardiologist and is the founding director of the Interdisciplinary Stem Cell Institute at the University of Miami’s Miller School of Medicine. He is a recipient of the Paul Beeson Physician Faculty Scholar in Aging Research Award and is an elected member of the American Association of Physicians and The American Society for Clinical Investigation. He is also an elected Fellow of the American Heart Association. He received a bachelor’s degree from the University of Pennsylvania and his M.D. from The Johns Hopkins University School of Medicine.

Lisa Locklear is CFO at Longeveron. She previously served as the senior vice president and CFO for Avanir Pharmaceuticals. Prior to Avanir, she held senior financial roles at GSN Games, CoreLogic, Ingram Micro, the Walt Disney Company, and Price Waterhouse, with assignments in Paris and London. She holds a bachelor’s degree in plant science from the University of California, Davis, and an MBA from the University of California, Irvine. She is a licensed CPA (inactive) and is a member of the American Institute of Certified Public Accountants, the California Society of CPAs, and Financial Executives International.

Dr. Nataliya Agafonova, M.D., is the Chief Medical Officer at Longeveron. She previously served as clinical development lead, senior medical director, and product development chair at Otsuka Pharmaceuticals. Before that, she was the clinical development lead and senior medical director at Bristol-Myers Squibb. She previously held senior leadership positions at Ardea Bioscience, Biogen, Amgen, and Genzyme Corporation. She earned an M.D. from the Ukrainian National Medical University and completed her internal medicine residency at Kharkov State University Hospital in Ukraine.

Certain statements in this corporate profile that are not historical facts are forward-looking statements made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995, which reflect management’s current expectations, assumptions, and estimates of future operations, performance and economic conditions, and involve risks and uncertainties that could cause actual results to differ materially from those anticipated by the statements made herein. Forward-looking statements are generally identifiable by the use of forward-looking terminology such as “believe,” “expects,” “may,” “looks to,” “will,” “should,” “plan,” “intend,” “on condition,” “target,” “see,” “potential,” “estimates,” “preliminary,” or “anticipates” or the negative thereof or comparable terminology, or by discussion of strategy or goals or other future events, circumstances, or effects. Factors that could cause actual results to differ materially from those expressed or implied in any forward-looking statements in this release include, but are not limited to, statements regarding the offer and sale of securities, the terms of the offering, about the ability of Longeveron’s clinical trials to demonstrate safety and efficacy of the Company’s product candidates, and other positive results; the timing and focus of the Company’s ongoing and future preclinical studies and clinical trials and the reporting of data from those studies and trials; the size of the market opportunity for the Company’s product candidates, including its estimates of the number of patients who suffer from the diseases being targeted; the success of competing therapies that are or may become available; the beneficial characteristics, safety, efficacy and therapeutic effects of the Company’s product candidates; the Company’s ability to obtain and maintain regulatory approval of its product candidates in the U.S., Japan and other jurisdictions; the Company’s plans relating to the further development of its product candidates, including additional disease states or indications it may pursue; the Company’s plans and ability to obtain or protect intellectual property rights, including extensions of existing patent terms where available and its ability to avoid infringing the intellectual property rights of others; the need to hire additional personnel and the Company’s ability to attract and retain such personnel; the Company’s estimates regarding expenses, future revenue, capital requirements and needs for additional financing; the Company’s need to raise additional capital, and the difficulties it may face in obtaining access to capital, and the dilutive impact it may have on its investors; the Company’s financial performance and ability to continue as a going concern, and the period over which it estimates its existing cash and cash equivalents will be sufficient to fund its future operating expenses and capital expenditure requirements. Additionally, Longeveron makes no assurance that any public offering of its securities as described herein will occur on the timelines, in the manner or on the terms anticipated due to numerous factors. Further information relating to factors that may impact the Company’s results and forward-looking statements are disclosed in the Company’s filings with the Securities and Exchange Commission, including Longeveron’s Annual Report on Form 10-K for the year ended December 31, 2022, filed with the Securities and Exchange Commission on March 14, 2023 and its Quarterly Report on Form 10-Q for the second quarter of 2023 filed with the SEC on August 11, 2023. The forward-looking statements contained in this corporate profile are made as of the date of this corporate profile, and the Company disclaims any intention or obligation, other than imposed by law, to update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise.

Investor Contact
Mike Moyer
LifeSci Advisors
Tel: 617-308-4306
Email: mmoyer@lifesciadvisors.com

Date prepared: August 31, 2023

Longeveron Inc. (NASDAQ: LGVN), closed Thursday's trading session at $1.81, up 4.023%, on 1,699,644 volume. The average volume for the last 3 months is 4.95M and the stock's 52-week low/high is $1.60/$44.00.

Recent News

D-Wave Quantum Inc. (NYSE: QBTS)

The QualityStocks Daily Newsletter would like to spotlight D-Wave Quantum Inc. (NYSE: QBTS).

Fast anneal is expected to impact various quantum computing applications, from advanced scientific research in quantum simulation to AI and solving real-world problems across wide spectrum of industries

It expands upon D-Wave's groundbreaking optimization achievements, utilizing the comprehensive coherent annealing quantum computing provided by D-Wave's Advantage(TM) systems and the cutting-edge Advantage2(TM) prototype

The introduction of the fast-anneal feature is poised to attract both commercial and academic researchers aiming to develop top-tier applications, broaden benchmarking investigations, and correlate heightened coherence with enhanced performance

D-Wave Quantum (NYSE: QBTS), a leader in quantum computing systems, software, and services, and the world's first commercial supplier of quantum computers, recently announced the launch of the fast-anneal feature, which is available on all D-Wave's quantum processing units ("QPUs") in the D-Wave Leap real-time quantum cloud service. Fast anneal is expected to impact a number of quantum computing applications, most notably advanced scientific research.

D-Wave Quantum Inc. (NYSE: QBTS) is a leader in quantum computing systems, software and services focused on delivering customer value via practical quantum applications for problems such as logistics, artificial intelligence, materials sciences, drug discovery, scheduling, fault detection and financial modeling. As the only provider building both annealing and gate-model quantum computers, the company is unlocking commercial use cases in optimization today, while building the technologies that will enable new solutions tomorrow.

D-Wave is a pioneer in quantum computing, with a history of delivering the world’s first commercial quantum computer; the first real-time quantum cloud service; countless hardware and software product and research milestones; and the planned first cross-platform quantum solution which will deliver both annealing and gate-model quantum computers to customers via an integrated platform. Its current commercial product offerings include: Advantage™ (fifth generation quantum computer), Leap™ (quantum cloud service), Launch™ (quantum computing onboarding service) and Ocean™ (full suite of open-source programming tools).

D-Wave’s relentless pursuit of practical quantum computing has resulted in the technology being used today by some of the world’s most advanced enterprises – more than 25 of the Forbes Global 2000 use D-Wave.

D-Wave’s commercial customers include blue-chip industry leaders like Volkswagen, Accenture, BBVA, NEC Corporation, Save-On-Foods, DENSO and Lockheed Martin. The company boasts an extensive IP portfolio featuring more than 200 issued U.S. patents and over 100 peer-reviewed papers published in leading scientific journals.

Founded in 1999, D-Wave is the world’s first commercial supplier of quantum computers. With headquarters and the Quantum Engineering Center of Excellence based near Vancouver, Canada, D-Wave’s U.S. operations are based in Palo Alto, California.

Advantage™ Quantum Computer

 

With the Advantage™ Quantum Computer, D-Wave has incorporated two decades of experience and over 10 years of customer feedback to create the first and only quantum computer designed for business. The platform features a new processor architecture with over 5,000 qubits and 15-way qubit connectivity. This is 2.5x more connections and more than double the number of qubits than the company’s previous generation quantum computer.

D-Wave’s quantum computers, first located in its facilities in British Columbia, have been available to North American users through its Leap™ quantum cloud service since 2018. It has since introduced new Advantage systems in Julich, Germany, and most recently, Marina Del Rey, California, which marked the availability of the first Advantage quantum computer physically located in the United States.

That new deployment is part of the USC-Lockheed Martin Quantum Computing Center (QCC) hosted at USC’s Information Sciences Institute (ISI), a unit of the University of Southern California’s prestigious Viterbi School of Engineering. Additionally, Amazon Web Services (AWS) and D-Wave announced that the U.S.-based system is available for use in Amazon 2racket, expanding the number to three different D-Wave quantum systems available to AWS users.

Leap Quantum Cloud Service

 

D-Wave’s customers interface with its systems through the Leap™ quantum cloud service. Leap delivers immediate, real-time access to the company’s Advantage quantum computer and quantum hybrid solver service, all with enterprise-class performance and scalability.

Leap allows developers proficient in Python to get started building and running quantum applications. Through a seamless and secure cloud-based connection, users can easily start solving complex problems of up to 1 million variables and 100,000 constraints.

Using Leap, D-Wave customers have developed quantum hybrid applications for use cases in manufacturing, logistics, financial services, life sciences, materials science, retail and transportation. By eliminating the need to wait hours, days or weeks to get good answers to a broad array of problems, D-Wave is helping businesses move forward.

D-Wave Launch

D-Wave Launch™ is the company’s onboarding platform aimed at helping businesses easily start their quantum journey. Through this program, D-Wave’s team of experts and partners aid enterprises in identifying best use cases for quantum and work with them to develop a proof of concept and production pilot.

From there, the team coordinates with customers to get their hybrid quantum applications up and running, providing ongoing Leap quantum cloud access to ensure the application is operating smoothly and delivering real business value.

Target Verticals

While the potential applications for quantum computing are effectively limitless, D-Wave has identified a number of industry verticals as key areas of focus for its quantum architecture, providing case studies for each. These include:

  • Manufacturing – D-Wave worked with Volkswagen to identify a commercial optimization application, the binary paint shop problem, which was run on D-Wave’s hybrid solver service. The solver outperformed four purely classical methods on problem sizes at commercial scale (N=3,000). In a separate project, similar inputs were tested using a leading ion trap system, which failed to find any commercial solution.
  • Life Sciences – Menten AI makes use of D-Wave quantum computing to assist in the design of novel therapeutic peptides—short strings of amino acids that can act as potent drugs. With the rise of COVID-19, D-Wave’s Advantage system made it possible to identify molecules that might be especially well-suited for binding and inhibiting the related spike protein, producing several promising peptide designs.
  • Finance – Multiverse Computing, a leader in developing quantum solutions for the financial sector, leveraged D-Wave’s hybrid solver service in a collaboration with BBVA, one of the world’s largest financial institutions. Multiverse demonstrated management strategies that far exceeded the granularity of traditional returns in a fraction of the time, helping BBVA identify a low-risk portfolio for investment.

Market Opportunity

The quantum computing total addressable market is projected to grow between $450 billion and $850 billion over the next 15 to 30 years, with between $5 billion and $10 billion of anticipated TAM growth coming in the next three to five years, according to Boston Consulting Group. Driving factors behind this growth include rising investments in quantum computing tech by governments and an increasing number of commercial use-cases.

Forward-thinking organizations see quantum as an opportunity to move ahead of the competition. From finding efficiencies and reducing waste to decreasing time to solution and solving problems abandoned due to complexity, the business value is real. According to data from 451 Research, 40% of large enterprises are already experimenting with quantum computing.

D-Wave is strategically positioned – in an industry with significant barriers to entry – as evident by a decades-long track record serving a roster of blue-chip customers. The company is singularly focused on helping its customers achieve clear value by leveraging quantum computing in practical business applications. With a full stack of systems, software, developer tools and services, D-Wave is working to enable enterprises, governments, developers and researchers to access the power of quantum computing, thereby providing an intriguing opportunity for prospective investors.

D-Wave’s current investor base includes PSP Investments, Goldman Sachs, BDC Capital, NEC Corporation, Aegis Group Partners and In-Q-Tel.

Leadership Team

Dr. Alan Baratz has served as the CEO of D-Wave since 2020. Previously, as Executive Vice President of R&D and Chief Product Officer, he drove the development, delivery, and support of all of D-Wave’s products, technologies, and applications. Dr. Baratz has over 25 years of experience in product development and bringing new products to market at leading technology companies and software startups. As the first president of JavaSoft at Sun Microsystems, he oversaw the growth and adoption of the Java platform from its infancy to a robust platform supporting mission-critical applications in nearly 80 percent of Fortune 1000 companies. He has also held executive positions at Symphony, Avaya, Cisco, and IBM. Dr. Baratz holds a doctorate in computer science from the Massachusetts Institute of Technology.

John Markovich is the company’s CFO. He brings to D-Wave over three decades of experience working with rapidly growing private and public technology companies across all stages of development. Mr. Markovich has directed the finance, accounting, tax, treasury, M&A, legal, operations, customer service, IR, HR, and IT functions for companies ranging from privately held pre-revenue startups to an NYSE-listed Fortune 500 multi-national company with over $1.2 billion in annual revenue. During his career, he has negotiated and closed over 150 debt, equity, M&A, and joint venture transactions exceeding $2.5 billion in value; over a dozen private placements; nearly a dozen M&A transactions; and several international joint ventures. Mr. Markovich holds a BS in Business from Miami University and an MBA from the Michigan State Graduate School of Business.

D-Wave Quantum Inc. (NYSE: QBTS), closed Thursday's trading session at $1.45, up 2.8369%, on 1,643,730 volume. The average volume for the last 3 months is and the stock's 52-week low/high is $44.00/$.

Recent News

SenesTech Inc. (NASDAQ: SNES)

The QualityStocks Daily Newsletter would like to spotlight SenesTech Inc. (NASDAQ: SNES).

SenesTech (NASDAQ: SNES), the leader in fertility control to manage animal pest populations, today announced the launch of Evolve(TM) Mouse. Evolve Mouse utilizes a breakthrough fertility solution to control mouse infestations. It is designated as a ‘minimum' risk product by the U.S. Environmental Protection Agency, posing little to no risk to human health and the environment. SenesTech will be accepting orders as of Monday, May 6, for shipment on or before May 15. According to the announcement, one of the company's lead distributors and online retailers, DIY Pest Control, has already committed to a sizable preorder and will immediately add Evolve Mouse to their website offerings. The launch of Evolve Mouse follows SenesTech's introduction of Evolve earlier this year, which is specially formulated for rats. The Evolve product line is the industry's only soft bait product line to control rodent populations by restricting fertility. "Evolve Mouse is a much-needed extension of the Evolve product line into an underserved market. We would expect the market for a mouse product would at least double the addressable market for the Evolve product line," said Fletcher Cline, President of DIY Pest Control.

To view the full press release, visit https://ibn.fm/bffGF

SenesTech Inc. (NASDAQ: SNES) is the rodent fertility control expert and the inventor of the only EPA-registered contraceptive for male and female rats. The company’s technology provides an innovative and humane method for managing rat populations.

SenesTech is focused on developing effective solutions that are grounded in science and proven through research, all while providing value to people, communities and the environment. The company’s passion is to create a healthier world by better controlling rat pest populations. This aim is critical, as, if left unchecked, a breeding pair of rats and their descendants can produce up to 15,000 pups after just one year.

The company strives for clean cities, efficient businesses and happy households – with a product that was scientifically designed to be effective without killing rats. SenesTech is committed to the sustainable, humane treatment of animals, improving the quality of all human life and enhancing environmental stewardship through the global application of its effective solution in fertility control technology.

SenesTech is headquartered in Phoenix, Arizona.

ContraPest®

SenesTech’s first product, ContraPest®, applies revolutionary technology to a global challenge that has persisted since the Middle Ages – the proliferation of rats in urban and agricultural settings. ContraPest® targets the reproductive capabilities of Norway and roof rats. As a highly palatable liquid, the formulation promotes sustained consumption, helping to reduce fertility in both male and female rats, bringing populations down and keeping them down.

The company’s flagship offering can be used as part of integrated pest management (IPM) programs – fitting seamlessly into all IPM programs – to help reduce reproduction and magnify the success of these protocols, or as a standalone solution for customers who want to reduce or eliminate the use of lethal rodent control methods.

In multiple, independent field deployments, ContraPest was shown to reduce rat activity over 90% when added to an existing IPM program.

ContraPest® is registered federally as a General Use Product.

Delivery Systems and New Products

In July 2023, SenesTech began to distribute a new delivery system for ContraPest®, the Isolate Bait System™. This new delivery system brings to market a simple design that enables more efficient deployment, incorporates an enhanced formulation of ContraPest® that is expected to provide improved performance of the fertility control bait in the field and is paired with a new bait station that is more space-efficient and economical.

The other delivery systems available for ContraPest include the Ultimate Bait System™, a tank and tray in a larger format for use with more severe infestations, and the Elevate Bait System™, a unique delivery system that targets above ground infestations, as with roof rats.

SenesTech, as of August 2023, is also in the final stages of releasing a soft bait formulation, which provides the unique attributes of proven fertility control in an industry-familiar format demanded by big box retailers, key e-commerce channels and leading industry pest management professionals.

Market Opportunity

According to SenesTech’s figures, rats cause over $27 billion in damage to public and private infrastructure annually in the United States. Rats also destroy 20% of the global stored food supply every year by consuming or contaminating it.

Rats are known to spread at least 35 diseases, globally posing a dangerous risk to public health and safety. Not only does this age-old problem persist despite extensive campaigns to eradicate it, but multiple sources have reported that post-COVID rat populations have boomed.

Poison-based control methods sicken rats, and they typically die slowly. An animal that eats a poisoned rat may also sicken or die. The global rodenticide market is projected to be worth $1.7 billion by 2026.

In one case study, results reported by the customer showed a $5,000 investment in ContraPest® saved more than $500,000 annually in reduced labor, loss and damage.

Management Team

Joel Fruendt is SenesTech’s President and CEO. He has 15 years of executive leadership in the vector and pest control industries as Vice President and General Manager of Clarke Environmental Inc., a leading vector and pest control products and services company. He has extensive expertise in the development and manufacturing of EPA-registered chemical control products, and the commercialization and sale of those products. He received the ‘Smart Leaders’ award from Smart Business Magazine and holds a bachelor’s degree in business from Illinois Wesleyan University.

Tom Chesterman is CFO at SenesTech. He has over 20 years of experience as the CFO of public companies in the life science, tech and telecommunications industries. Most recently, he was the Vice President and Treasurer of GCI, a telecommunications company. Previous to that, he was the CFO of life science companies Bio-Rad Laboratories, Aradigm and Bionovo. He has a bachelor’s degree from Harvard University and an MBA from the University of California at Davis.

Dan Palasky is Chief Technical Officer at SenesTech. Previously he held the title of Vice President of Research & Development at PLZ Corp., a manufacturer of chemical consumer products, serving as the technical expert for its entire product portfolio. He started his career with Camie-Campbell, Inc., as a chemist in the R&D department. Mr. Palasky received his bachelor’s degree in chemical engineering from the Missouri University of Science & Technology and his MBA in Project Management from Aspen University.

SenesTech Inc. (NASDAQ: SNES), closed Thursday's trading session at $0.8627, up 9.5214%, on 200,819 volume. The average volume for the last 3 months is and the stock's 52-week low/high is $0.52/$19.20.

Recent News

Bebuzee Inc. (OTC: BBUZ)

The QualityStocks Daily Newsletter would like to spotlightFathom Bebuzee Inc. (OTC: BBUZ) .

Bebuzee (OTC: BBUZ), a pioneer in the social platform and streaming service industry, today announced the launch of its game-changing Super App. According to the announcement, this all-in-one app is set to redefine the digital landscape in the United States and Europe. It is a testament to Bebuzee's commitment to pushing the boundaries of technology, seamlessly combining multiple services into a single, intuitive platform. Bebuzee's Super App transcends the limitations of traditional apps, offering an unparalleled experience that merges entertainment, e-commerce, real estate and communication. The app is expected to revolutionize how users interact with digital platforms. The announcement noted that as the app gains traction in the U.S. and European markets, it is poised to generate substantial returns, solidifying Bebuzee's position as a leader in digital innovation. "We are on the cusp of unveiling a product that will completely transform the way people interact with digital platforms," said Joe Onyero, CEO of Bebuzee. "Our Super App is not just a technological feat; it's a testament to our unwavering commitment to innovation and user-centric design. We are confident that this app will resonate with users in the U.S. and European markets, offering them an unmatched digital experience."

To view the full press release, visit https://ibn.fm/PThiD

Bebuzee Inc. (OTC: BBUZ), formerly Engage Mobility Inc., is a social platform and streaming service focused on development and deployment of America’s first superapp. The superapp will allow members to watch a wide variety of content, such as movies, series, documentaries and talk shows, on any internet-connected device.

Bebuzee’s technology scans the world’s news, features and information-flow to give its dedicated readers the best of the internet in one place – a one-stop platform for breaking news, interesting and important blogs, videos and photos.

The core features of the superapp include video streaming; photo sharing; Bebuzee Messaging service, which allows users to send text and voice messages and make voice and video calls; Shortbuz, used to make a variety of short-form entertaining videos; Blogbuz, a resource for people without time to scavenge the internet and other sources for news and information; Properbuz global real estate search; global tradesmen search; location reviews of neighborhoods, cities and even regions to help others find their ideal rental or real estate purchase; ShoppingBuz, a unique technology-driven e-commerce platform which gives merchants incredible tools to sell their products; Bebuzee Pay, a mobile payment and digital wallet service that allows users to make mobile payments and online transactions; TravelBuz, an online travel booking service; EventBuz, a ticket exchange and resale platform; and FlightBuz, a flight search engine.

The company is headquartered in Miami.

Introducing the Superapp to Western Markets

A superapp is a mobile phone app that offers a wide range of services within a single platform. This technology allows users to access various services without downloading and switching between multiple apps.

While superapps are popular in many parts of the world, including Latin America, Africa, the Middle East, Asia and Russia, they have achieved little adoption in Western markets. Perhaps the most widely known superapp is WeChat, which is estimated to have as many as 1.24 billion users, mostly in China.

Bebuzee aims to be the first developer to introduce and grow to widespread popularity a superapp in the U.S. and Europe. It took a strong step toward achieving this goal during the COVID-19 pandemic, when Bebuzee’s user base surged by 78% with over 42 million new users.

Whereas most social platforms are generic and only local postings make them somewhat relevant to local communities, Bebuzee has localized its platform for most countries by providing local content, entertainment and information that is frequently updated and refreshed.

The company says the average age of its superapp users is 39, with female users making up 62.8% of its user base. Its monetization strategy includes sales of video advertising, sponsored posts, banner ads and premium listings, as well as promotion of featured brands and property listings.

Market Opportunity

A report from Allied Market Research, a global market research, consulting and advisory firm, estimated that the worldwide superapps market was valued at $58.6 billion in 2022. The report projects the market to expand to $722.4 billion by 2032, growing at a CAGR of 28.9% for the forecast period.

The report identifies a few of the most popular superapps as Rappi in Latin America, Snapp in Iran, Line in Japan and Yandex Go in Russia and Kazakhstan.

Increasing adoption of mobile services and growing advancements in digital technologies are driving the growth of this market. In addition, a rise in government support for promoting the use of superapps is lending to expansion, according to the report.

Integration of blockchain technology in superapps is likewise anticipated to provide numerous opportunities for the expansion of the market during the forecast period, the report states.

Management Team

Joseph Onyero is Founder and CEO of Bebuzee. He has a background of managing multiple products from ideation to market launch and profitable monetization and has been building commercial web presences since 2005. He has worked as a Chief Marketing Officer and in business development. He previously owned and operated a travel and tourism company. He began in 2005 working on the concept and features that have evolved into the Bebuzee suite. He has grown Bebuzee from a living room start-up into a U.S. publicly traded company.

Claudia S. Spagnuolo is Chief Operating Officer at Bebuzee. She began with the company in 2014 as a user experience manager before being promoted to CMO in 2017. She previously worked as an assistant marketing director at the National Secretariat of the union CISL in Italy. Prior to that, she also worked as a researcher at the Complutense University of Madrid on issues of corporate management. She speaks three languages and holds a bachelor’s in political science and a master’s in administration from the University of Perugia in Italy.

Bebuzee Inc. (OTC: BBUZ), closed Thursday's trading session at $0.11, up 57.1429%, on 86,899 volume. The average volume for the last 3 months is and the stock's 52-week low/high is $0.01955/$0.359.

Recent News

Horizon Fintex | Upstream

The QualityStocks Daily Newsletter would like to spotlight Horizon Fintex | Upstream

Last week, Google Cloud launched a new portal with various resources for blockchain developers, including tutorials on how to create nonfungible tokens and data sets. The launch of the Web3 portal has been met with mixed reactions from the cryptocurrency industry however, with some expressing their disappointment about the new portal. Unchained VP of product marketing, Phil Geiger, stated in a post made on X last week that the platform had no native lighting support of Bitcoin. He added that this seemed like an oversight that ignored the most important cryptocurrency. A crypto trader by the pseudonym MartyParty on X wrote that he wasn't impressed with Google, adding that the search engine was way behind. This trader has more than 80,000 followers on X. A month earlier, BigQuery under Google added 11 blockchain networks to its data warehouse. Those networks include Arbitrum, Avalance, Fantom, Cronos, Tron, Mumbai testnet by Polygon, Polygon's mainnet, Polkadot, Optimism, Near and Ethereum's Görli testnet. As more major tech companies take steps to facilitate Web3 technologies on their platforms, the number of Web3 solutions that enterprises such as Horizon Fintex integrate could also see an uptick.

Horizon Fintex is a software business specializing in compliant securities solutions. The company aims to facilitate the future of capital markets by leveraging the regulatory experience of Wall Street bankers and the proven track record of technology veterans to bring focus to compliance, efficiency, security and transparency.

Horizon’s flagship product is the revolutionary trading app ‘Upstream’, a MERJ Exchange Market, and the first regulated market powered by a blockchain to offer both digital securities and NFT trading. Upstream traders experience T+0 settlement, best bids and offers displayed on a transparent public orderbook that prevents predatory market practices – all from a user-friendly trading app.

Products

Horizon Fintex offers a full suite of end-to-end blockchain-enhanced software solutions to create a seamless experience for both issuers and investors. Its product suite includes:

  • Securitization & IssuanceETSware is an end-to-end Electronic Trading System streamlining capital raising from primary issuance through compliant secondary trading.
  • KYC Compliance OnboardingKYCware is a white label Know Your Customer (KYC) and Anti-Money Laundering (AML) compliance software solution offering best-in-class cryptographic security to compliantly onboard and verify user identity through a smartphone application.
  • AML Screening SoftwareAMLCop offers advanced Anti-Money Laundering (AML) software to streamline the verification of user details against a proprietary database of global sanctions, politically exposed persons (PEPs) and watchlists.
  • Cap. Table Management ToolsCustodyWare equips registered U.S. transfer agents with next-generation cap. table management software to manage securities on behalf of their clients pursuant to an SEC-registered or exempt securities offering.
  • Exchange & Trading App TechnologyOpen Order Book offers Ethereum blockchain securities exchange software to power the next generation of trading venues for digital assets.

Upstream – The Horizon-Powered Trading App

Upstream is a joint venture with MERJ Exchange (merj.exchange), an affiliate of the World Federation of Exchanges.

Upstream aims to be the premiere global trading hub offering issuers around the world exposure to a digital-first investor base that can trade using USDC digital currency along with credit, debit, PayPal, and USD (fiat) to increase liquidity and enhance price discovery; while also offering investors access to dual-listed companies, IPOs, crowdfunded companies, U.S. & Int’l. equities, digital coupons and NFTs directly from a user-friendly trading app.

Upstream aims to unlock liquidity for investors of all levels while offering industry-leading levels of transparency, accessibility and investor protections enforced using Ethereum blockchain technology.

Management Team

Brian Collins is the CEO of Horizon Fintex. He founded the company in 2010. From 1999-2010, Mr. Collins was CEO of Abbey Technology in Switzerland, specializing in the design of trading software for Swiss banks. Prior to this, he worked for Credit Suisse in Zürich, designing and building proprietary equity trading solutions. Mr. Collins graduated in 1990 with a BS in Computer Systems from the University of Limerick, Ireland.

Mark Elenowitz is the company’s President. He is a Wall Street veteran with over 29 years of experience. Mr. Elenowitz was the co-founder of a U.S. broker dealer and is Managing Director of two U.S. broker dealers, responsible for advising clients on compliance, capital structure and capital market navigation. He was responsible for leading the first successful Reg A+ IPO of a company to list on the NYSE and others which listed directly onto Nasdaq. He is a noted speaker at Small Cap and Reg A events, including the SEC Small Business Forum, and has been profiled in BusinessWeek and CNBC, as well as several other publications. Mr. Elenowitz is a graduate of the University of Maryland School of Business and Management with a BS in Finance and holds Series 24, 62, 63, 79, 82 and 99 licenses.

Dr. Andrew Le Gear is the CTO of Horizon Fintex. Prior to joining the company in 2013, he worked as a software engineer with Dell Inc. (2012-2013) and Lehman Brothers and Nomura Plc. (2007-2012). Dr. Le Gear was a co-founder of Juneberi Ltd., a research-driven software tech start-up (2004-2007). He graduated in 2006 with a Ph.D. in Computer Science from the University of Limerick, Ireland.

Peter Hall is the company’s CIO. Prior to joining Horizon Fintex in 2011, he worked at Microsoft (2008-2011), Atos Origin (2004-2008) and AIT Group Plc. (1998-2002). Mr. Hall has held CISSP certification since 2010. He graduated from the University of Sheffield, UK in 1995 and earned an MS from the University College London in 2006.

Mike Boswell is the CFO of Horizon Fintex. A Wall Street veteran, he co-founded a U.S. broker dealer and served as Chief Compliance Officer. Mr. Boswell was also Managing Director of TriPoint Capital Advisors, a merchant banking and financial consulting company, and CFO of Mission Solutions Group, a privately held defense sector firm. He earned an MBA from John Hopkins University and a BS in Mechanical Engineering from the University of Maryland. Mr. Boswell holds Series 24, 62, 63, 79, 82 and 99 licenses.

Recent News

chart

Astrotech Corp. (NASDAQ: ASTC)

The QualityStocks Daily Newsletter would like to spotlight Astrotech Corp. (NASDAQ: ASTC).

Last week, Governor Gavin Newsom of California directed the state's Department of Alcoholic Beverage Control and the Department of Public Health to issue notices on the distribution and sale of illicit hemp products. This comes after it was determined that youth in the state can be exposed to intoxicating drugs through illicit hemp products. The objective of these notices is to ensure that laws are complied with, to protect the youth and others in the state from possibly harmful hemp-infused products while restricting their access to those products. Violations of this act are misdemeanors and are subject to fines and, in serious cases, imprisonment. The public health department also has the authority to pursue administrative disciplinary action against licensees that sell hemp products which violate the aforementioned act. The process of rooting out illegal hemp products from the state could benefit from the testing equipment commercialized by many companies such as Astrotech Corp. (NASDAQ: ASTC), so that businesses that are selling legitimate products don't become victimized inadvertently.

Astrotech Corp. (NASDAQ: ASTC) is an instrumentation company that designs, manufactures and commercializes solutions. Its solutions include mass spectrometry, process controls, chemical detectors and medical disease detection.

The company was established in 1984 and, prior to 2009, was known as SPACEHAB Inc., a NASA contractor offering technology originally developed for NASA to monitor air quality on the International Space Station. When the Space Shuttle program ended, the company focused on its satellite processing and mass spectrometer instrumentation units and adopted the Astrotech name.

In 2014, Astrotech sold its satellite subsidiary to focus on its Astrotech Technology Inc. (ATi) mass spectrometry solutions, which offer a number of advantages over competing platforms. Notably, Astrotech’s ATi technology is ruggedized, rapid, simple to use and customizable, with hands-free calibration and tuning.

Between 2016 and 2019, the company secured U.S. patents for its technology and achieved European Union (ECAC) certification for the TRACER 1000™, the world’s first mass-spec Explosives Trace Detector (ETD) used in airports worldwide. Astrotech continues to innovate and add to its suite of products, including AgLAB-1000, a process control system, and the BreathTest 1000, a disease detection solution.

Astrotech is headquartered in Austin, Texas.

Subsidiaries

Astrotech Technologies Inc.

Astrotech Technologies Inc. (ATi) owns and licenses the platform mass spectrometry technology originally developed by 1st Detect. This technology is designed to be less expensive, smaller and easier to use than traditional mass spectrometers.

Unlike other technologies, ATi works under high vacuum, which eliminates competing molecules, yielding higher resolution and fewer false alarms. The company’s intellectual property includes 18 granted patents, along with extensive trade secrets.

ATi exclusively licenses the Astrotech Mass Spectrometer Technology to the three wholly owned subsidiaries of Astrotech.

1st Detect Corp.

1st Detect Corp. developed the TRACER 1000, the world’s first mass spectrometry-based explosives and narcotics trace detector. 1st Detect ETDs were developed for use at airports, cargo facilities and other secured locations and borders worldwide.

1st Detect’s commercial sales of the TRACER 1000 ETD, consumables and recurring maintenance services brought in $750,000 in total revenue during the fiscal year ended June 30, 2023. The Astrotech subsidiary recently secured two orders for a total of 24 Tracer 1000 units from two Romanian security and telecommunications companies, to be delivered during calendar 2023.

AgLAB Inc.

AgLAB Inc. is developing a series of mass spectrometers for use in the hemp and cannabis market, with an initial focus on optimizing yields in the distillation processes.

AgLAB, which uses the company’s proprietary AgLAB 1000-D2™ mass spectrometer, has been proven to improve distillation oil yields and bottom-line profits for hemp and cannabis producers. During field trials, AgLAB was able to improve ending-weight yields by an average of 24%.

BreathTech Corp.

BreathTech is developing the BreathTest-1000™, a breath analysis tool to screen for volatile organic compound (“VOC”) metabolites found in a person’s breath that could indicate they may have a compromised condition including but not limited to a bacterial or viral infection. The company believes that new tools to aid in the battle against COVID-19 and other diseases remain of the utmost importance to help more quickly identify that an infection may be present.

Market Opportunity

A report by Mordor Intelligence, a research and advisory firm, put the global mass spectrometry market at $6.37 billion in 2023. The market is forecast to grow to $8.63 billion by 2028, achieving a CAGR of 6.25% during the forecast period.

One of the major driving factors for the growth of the mass spectrometry market is technological advancements in mass spectrometer devices, the report states. Key market players are continuously working toward advancing their existing products and launching innovative and advanced mass spectrometer devices.

Another major factor that is expected to boost market growth is increasing research and development expenditure by both government and private entities, according to the report. Mass spectrometry devices are also being used in the detection and analysis of COVID-19 and other disease samples, which may have a positive impact on the market.

Management Team

The Astrotech leadership team includes management executives, as well as industry and technology experts. The company continues to actively expand its talent pool to meet evolving demands.

Thomas B. Pickens III is Chairman, CEO and Chief Technology Officer of Astrotech Corp. He also serves as CEO of Astrotech subsidiaries ATi, 1st Detect, AgLAB Inc. and BreathTech Corp. Previously, he was the founder and president of Beta Computer Systems Inc. and T.B. Pickens & Co. He was founder and general partner of Grace Pickens Acquisition Partners L.P and managing partner of Sumpter Partners. He also served as CEO of Catalyst Energy Corporation and United Thermal Corporation and as president of Golden Bear Corp., United Hydro Inc. and Slate Creek Corp. He received a B.A. in Economics, Computer Science and Engineering from Southern Methodist University.

Jaime Hinojosa, CPA, is CFO at Astrotech Corp. He joined the company in 2015 and has served as its Corporate Controller since 2019. His previous roles with the company include Director of Finance, from 2017 to 2019, and Assistant Controller, from 2015 to 2017. Prior to joining Astrotech, Mr. Hinojosa worked as an Accounting Manager for O’Reilly Auto Parts and gained public accounting experience as an Audit Manager at Burton McCumber & Cortez LLP.

Astrotech Corp. (NASDAQ: ASTC), closed Thursday's trading session at $9.05, off by 0.5920539%, on 782 volume. The average volume for the last 3 months is and the stock's 52-week low/high is $7.00/$15.11.

Recent News

Mullen Automotive Inc. (NASDAQ: MULN)

The QualityStocks Daily Newsletter would like to spotlight Mullen Automotive Inc. (MULN).

Mullen Automotive (NASDAQ: MULN), an emerging electric vehicle ("EV") manufacturer, has partnered with Pritchard EV, a national leader in the adoption of EVs with commercial fleets and Mullen's recently announced dealer partner, and Mobile Road Services Solution ("MRSS"), a leading upfitter for the Roadside Service Industry. The tripartite partnership is geared toward the debut of the Mullen ONE, Class 1 EV cargo van roadside assistance vehicle upfit, currently on display at the American Towman Showcase in Las Vegas, Nevada. According to the announcement, Pritchard EV worked with MRSS to identify the Mullen ONE EV cargo van as their first joint offering for the roadside service market. The Mullen ONE EV Cargo Van is the only Class 1 Cargo van available today. "Mobile roadside assistance is a great segment for our commercial EVs and partnering with Pritchard and MRSS is a great opportunity within the space," said David Michery, CEO and Chairman of Mullen Automotive. "Today, both companies hit the ground running in Las Vegas with our Class 1 EV cargo van which is on display and receiving great feedback at the tradeshow. We look forward to success with both Pritchard and MRSS."

To view the full press release, visit https://ibn.fm/7Utk1

Mullen Automotive Inc. (NASDAQ: MULN) is a Southern California-based automotive company that owns and partners with several synergistic businesses working toward the unified goal of creating clean and scalable energy solutions. Mullen has evolved over the past decade in sync with consumers and technology trends. Today, the company is working diligently to provide exciting EV options built entirely in the United States and made to fit perfectly into the American consumer’s life. Mullen strives to make EVs more accessible than ever by building an end-to-end ecosystem that takes care of all aspects of EV ownership.

Commencement of Trading on Nasdaq

On November 5, 2021, Mullen announced its commencement of trading on the Nasdaq Capital Market.

“Today is a monumental day for Mullen Automotive. I am especially proud of our team, investors and all who have believed in Mullen and taken us to this point as a publicly traded company on the Nasdaq Capital Market,” David Michery, CEO and Chairman of Mullen Automotive, stated in the news release. “Trading on Nasdaq now opens us up to new investors, both institutional and retail shareholders, and broadens our awareness and company profile, while increasing awareness of Mullen and our technology platform and opening new opportunities in EV and beyond. The road ahead has never been brighter for Mullen, and I am proud to lead us into the future.”

The milestone came in the wake of the company’s stock-for-stock merger with Net Element Inc.

The Mullen FIVE

The Mullen FIVE EV Crossover, debuting at the Los Angeles International Auto Show (LAIAS) on November 17, 2021, embodies Mullen’s Southern California roots with an inspired design focused on two complementary Golden State themes – California landscape and California urban.

The FIVE is built on an EV Crossover skateboard platform that offers multiple powertrain configurations and trim levels in a svelte design that is Strikingly Different™ and exciting to experience in person.

Prior to the start of LAIAS, the Mullen FIVE was selected as a finalist by the LA Auto Show for Top EV SUV in the ZEVA “People’s Choice” Awards.

LAIAS provides Mullen an opportunity to display multiple variants of the FIVE model while also showcasing its powertrain, battery and charging technology. The company intends to bring the FIVE to market in 2024, and reservations are currently open here.

Mullen’s development portfolio also includes EV Fleet Vans, which it intends to bring to market in Q2 2022, and the pure electric, high performance Mullen DragonFLY.

Expansion of Manufacturing Capacity

On November 2, 2021, Mullen announced plans to expand its facility in Robinsonville, Mississippi.

Mullen’s Advanced Manufacturing and Engineering Facility (AMEC) currently occupies 124,000 square feet of manufacturing space. The total available land on the property is over 100 acres, and Mullen is moving ahead with plans to build out another 1.2 million square feet of manufacturing space to support class 1 and class 2 EV cargo vans and the Mullen FIVE EV Crossover.

On the expanded site, Mullen plans to build a body shop, a fully automated paint shop and a general assembly shop.

EV Market Outlook

The global EV market was reported to consist of 3,269,671 units in 2019, a figure that is expected to grow at a CAGR of 21.1% through 2030 to a total of 26,951,318 units worldwide. This market’s monetary value was estimated at $162.34 billion in 2019 and is expected to grow at a CAGR of 22.6%, resulting in an approximate value of $802.81 billion by 2027. The primary driver for this exponential growth is a worldwide increase in vehicle emissions regulations.

Management Team

David Michery is the CEO and Founder of Mullen and has been leading the company and its divisions since inception in 2014. With over 25 years of executive management, marketing, distressed assets, and business restructuring experience, Mr. Michery brings a wealth of relevant knowledge and expertise to the Mullen brand. He has notably created 12 trademarks so far to develop the company brand and vision.

Mr. Michery is working toward a sustainable future accessible to all by creating a suite of clean-energy electric vehicles at varied price points. With entirely U.S.-based manufacturing and operations, he is also determined to have Mullen Technologies play a role in shaping a self-sustaining local economy by creating more jobs in America.

Mr. Michery manages risks and company expectations as a pathway to success and has personally overseen several businesses that totaled over $1 billion in transactions. His key strength is the ability to be fiscally responsible and lead teams to complete projects on time and within budget. As a seasoned professional in this space, Mr. Michery has demonstrated skill in building businesses from the ground up and into successful entities that subsequently sold for hundreds of millions of dollars.

Mullen Automotive Inc. (MULN), closed Thursday's trading session at $4.63, off by 5.7026%, on 4,026,770 volume. The average volume for the last 3 months is and the stock's 52-week low/high is $2.3565/$2250.00.

Recent News

SOBRsafe Inc. (NASDAQ: SOBR)

The QualityStocks Daily Newsletter would like to spotlightFathom SOBRsafe Inc. (NASDAQ: SOBR).

SOBR safe (NASDAQ: SOBR), a provider of next-generation, transdermal alcohol-detection solutions, continues to strengthen its position as it announces new contracts. The company recently signed a hardware/software agreement with a three-facility behavioral health provider as well as a reseller agreement with a new channel partner servicing the justice, workplace-safety and family-law markets. These new contracts expand the company's footprint in key markets, including Southern California and Texas. Based in California, the three-facility provider offers a full continuum of care, including inpatient detoxification and residential treatment to outpatient services. The customer enabled point-of-care screening by purchasing and installing a SOBRcheck(TM) device in each of its three facilities. Texas-based Alcohol Monitoring Solutions DBA 365IID has purchased both SOBRcheck devices and SOBRsure(TM) devices; the company plans to order additional devices in the next month. SOBRsafe has signed 18 new accounts in 2024, compared to three accounts in 2023.

To view the full press release, visit https://ibn.fm/sve7s

SOBRsafe Inc. (NASDAQ: SOBR) is a provider of a game-changing transdermal (touch-based) alcohol detection technology that can improve workplace safety and provides advanced screening and monitoring solutions for the behavioral health industry.

Alcohol misuse is the fourth leading cause of preventable death in the U.S., and the seventh worldwide. Nearly half of all industrial accidents with injuries are alcohol-related, and 1-in-10 U.S. commercial drivers tests positive for alcohol – the highest rate in the world. Despite these statistics, prevention and monitoring solutions have not kept pace with this epidemic. Legacy detection technologies are invasive and inefficient, unhygienic and unconnected. SOBRsafe believes there is a better way.

The company has developed a patent-pending alcohol detection device called SOBRcheck™ for use in detecting alcohol in humans, with just the touch of a finger. SOBRsafe’s next-generation transdermal technology detects and instantaneously reports the presence of alcohol as emitted through a user’s skin. No breath, blood or urine sample is required. SOBRsafe believes its technology is a superior, hygienic alternative to traditional breathalyzers for frontline, preventative applications.

With a powerful backend data platform, SOBRsafe provides humane, passive and connected alcohol detection for the behavioral health, transportation, oil and gas, judicial and consumer markets.

A preventative solution in historically reactive industries, SOBRsafe technology is being deployed for commercial fleets, workplaces, alcohol rehabilitation, probation management and teen drivers. This monitoring technology helps prevent intoxicated workers from taking the factory floor or drivers from receiving the keys to a truck, bus or family car. An offender is immediately flagged, and an administrator is empowered to take the appropriate corrective actions.

SOBRsafe technology is commercially available for access control (SOBRcheck), wearable use (SOBRsure™) and licensing or white labeling.

The company is headquartered in the Denver (CO) Technology Center.

Products

The SOBRsafe technology is integrated within the company’s robust and scalable data platform, producing statistical and measurable user and business data.

SOBRsafe™

With a mission is to save lives, increase productivity, create significant economic benefits and positively impact behavior, SOBRsafe developed the scalable, patent-pending SOBRsafe™ platform for non-invasive alcohol detection, real-time reporting and historical data aggregation.

SOBRsafe is a solution that has broad applications in behavioral health, fleet and facility safety, youth drivers and judicial markets.

SOBRcheck™

SOBRcheck is the company’s stationary identification and alcohol monitoring product, providing a quick, specific-point-in-time test for the presence of alcohol. In hygienic, real-time fashion, SOBRcheck verifies user identity and determines the absence or presence of alcohol.

SOBRcheck provides an administrator immediate results – delivered securely – to aid in the efficient management of an existing substance abuse policy.

SOBRsure™

SOBRsure is the company’s transdermal, alcohol-detecting wearable. SOBRsure provides continuous, mobile alcohol monitoring. The band’s advanced alcohol safety technology discreetly detects and instantaneously reports the presence of alcohol in the body. Additionally, SOBRsure provides app-based alcohol detection alerts, pinpoint location tracking and band-removal notifications.

The SOBRcheck and SOBRsure revenue models consist of two components: (1) a hardware device purchase and (2) a recurring monthly SaaS subscription fee.

Design, manufacturing, quality testing and distribution for all SOBRsafe devices takes place in the U.S.

 

Market Opportunity

A report from Data Bridge Market Research, an international market research and consulting firm, estimated the global alcohol sensor market at $2.3 billion in 2022. The market is forecast to reach a value of $6.3 billion by 2030, recording a CAGR of 13.7% over the forecast period.

Market growth drivers, as cited by the report, include rising alcohol consumption rates, more stringent laws pertaining to alcohol consumption and new, more effective technologies that facilitate detection and enforcement.

Greater awareness of alcohol consumption as a potential threat to public and workplace safety has led to increased emphasis on preventing operation of motor vehicles and machinery by those under the influence of alcohol and promoting responsible alcohol consumption, as the report details.

Management Team

David Gandini is Chairman and CEO of SOBRsafe. He most recently served as president of IPS Denver, a bank card personalization company. Prior to that, Dave was the COO at First World Communications, a U.S. internet and data center provider, and participated in its successful IPO. He previously founded Pace Network Services and facilitated a successful exit to ICG Communications. Dave also co-founded Detroit-based Digital Signal in the fiber optic long haul market sector, where he executed a successful exit to SP Telecom.

Chris Whitaker, CPA, is CFO of SOBRsafe. Previously, Chris had served as the Company’s Vice President of Finance and Accounting. He has held various executive finance positions with large public multi-national corporations and small entrepreneurial companies throughout a progressive 30-year career that began with KPMG. Chris was formerly President – Americas and Vice President of Finance and Administration for public, multinational corporation Elixinol. He also served as the Managing Director of AEGIS Financial Consulting, leading a team of consultants in providing fractional CFO and financial consulting services to a wide variety of businesses in the public and private sectors.

Scott Bennett is EVP, Business Operations at SOBRsafe. He has more than 20 years of experience as a senior executive in technology-driven enterprises. Prior to joining SOBRsafe, he co-founded cybersecurity firm GBprotect and served as its COO until its successful sale to Nuspire. He previously served as Chief Technical Officer/Chief Information Security Officer of fintech businesses Catalyst Card Company and Integrated Printing Solutions.

SOBRsafe Inc. (NASDAQ: SOBR), closed Thursday's trading session at $0.2899, off by 0.0344828%, on 55,581 volume. The average volume for the last 3 months is and the stock's 52-week low/high is $0.2004/$2.33.

Recent News

SuperCom Ltd. (NASDAQ: SPCB)

The QualityStocks Daily Newsletter would like to spotlight SuperCom Ltd. (NASDAQ: SPCB) .

SuperCom Ltd. is focused on developing its portfolio of products in support of advanced electronic monitoring ("EM") solutions, and reported last month record-level revenues and EBITDA during the past year

SuperCom's recent positive financials report represents the results of the company's efforts to introduce non-incarceration EM alternatives around the world, with inroads in Europe and the U.S. resulting in significant contracts

Electronic technology for tracking criminal offenders and other court-administered programs provides a more economical approach to security than incarceration in cases where such options applicable

Electronic-monitoring ("EM") security solutions developer SuperCom (NASDAQ: SPCB) has seen its revenues and gross margin grow dramatically as it serves a worldwide market for court-administered security needs and other identity technology concerns.

SuperCom Ltd. (NASDAQ: SPCB) provides secured solutions for the e-government, IoT and cybersecurity sectors. Since 1988, the company has been a trusted global provider of traditional and digital identity offerings, providing cutting-edge electronic and digital security solutions to governments and organizations, both private and public, around the world.

SuperCom’s mission is to revolutionize the public safety sector worldwide through proprietary electronic monitoring technology, data intelligence, and complementary services.

The company is headquartered in Tel Aviv, Israel, with offices in California and other regions in the U.S.

Business Units

IoT and Connectivity

SuperCom IoT products and solutions provide advanced electronic monitoring solutions and services to criminal justice agencies, enabling customers to detect unauthorized movement of people, vehicles, and other monitored objects. The company provides an all-in-one, field-proven PureSecurity offender monitoring suite, accompanied by services such as GPS monitoring, home detention, domestic violence prevention, and more. The company’s services are specifically tailored to meet each client’s needs.

SuperCom’s proprietary Puresecurity suite of hardware, connectivity, and software components is the foundation for its criminal justice services and offerings. SuperCom is leveraging its extensive technology expertise to implement groundbreaking artificial intelligence (AI) technologies into various parts of its core offerings. By leveraging the power of AI, SuperCom’s PureSecurity platform can offer new abilities, such as amplified data analysis, predictive modeling, and streamlined automation – all geared toward optimizing decision-making and operational efficiency.

Competitive advantages of SuperCom’s technology include:

  • Long Battery Life (No Tag Charging Required)
  • Ultra Lightweight Form Factor
  • Next-Gen Location Tech
  • Protection of Domestic Violence Victims
  • And More

 

Cybersecurity

In 2015, SuperCom identified the cybersecurity market as a fast-growing space with significant advantages due to synergistic technologies and a shared customer base with its e-Gov and IoT business units. Consequently, SuperCom strategically acquired Prevision Ltd., a company with a strong presence in the market and a broad range of competitive cybersecurity services.

During the first quarter of 2016, SuperCom acquired Safend Ltd., an international provider of cutting-edge endpoint data protection guarding against corporate data loss and theft through content discovery and inspection, encryption methodologies, and comprehensive device and port control.

Both acquisitions significantly expanded the breadth of the company’s global cybersecurity capabilities.

e-Gov

Through proprietary e-government platforms and innovative solutions for traditional and biometrics enrollment, personalization, issuance, and border control services, SuperCom has helped governments, and national agencies design and issue secured multi-identification, or Multi-ID, documents and robust digital identity solutions to their citizens, visitors, and lands.

The company has focused on expanding its activities in the traditional identification, or ID, and electronic identification, or e-Gov, markets, including the design, development, and marketing of identification technologies and solutions to governments in Europe, Asia, America, and Africa using SuperCom’s e-Government platforms.

Market Opportunity

Data from Berg Insight estimates the market for electronic monitoring solutions will grow from $1.2 billion in 2021 to $2.1 billion in 2026, marking a CAGR of 10.8% for the forecast period.

High recidivism rates, prison overcrowding, and soaring incarceration costs are some factors that are driving the electronic monitoring of offenders’ market growth.

An analysis by ReportLinker forecasts that the global cybersecurity market will grow from an estimated value of $173.5 billion in 2022 to $266.2 billion by 2027, achieving a CAGR of 8.9% for the period.

The increased number of data breaches worldwide, the ability of malicious actors to operate from anywhere in the world, the links between cyberspace and physical systems, and the difficulty of reducing vulnerabilities and consequences in complex cyber networks are some factors driving the cybersecurity market growth.

Management Team

Ordan Trabelsi is President and CEO of SuperCom. He has over 15 years of experience as CEO, growing high-tech companies globally. He also has experience in research and development and product innovation, as well as hands-on experience in cybersecurity, encryption, advanced mathematics, and mobile and internet network technologies. Prior to joining SuperCom, he served as co-founder and CEO of Klikot Inc., a global social networking company. He holds an MBA from Columbia University and a B.Sc. in Computer Engineering from The Technion: Israel Institute of Technology.

Barak Trabelsi is COO of SuperCom. He has expertise in big data, cyber, mobile, and internet network technologies, as well as extensive experience in product development and strategies. Prior to joining SuperCom, he served as Senior Product Manager at Equinox Ltd. Before that, he served for four years as VP of R&D at Sigma Wave, a wireless, security, and internet-focused company. He holds a B.Sc. in Computer Science and Business, as well as an MBA from Tel Aviv University.

Gil Alfi is VP of Sales at Safend Ltd., SuperCom’s cybersecurity subsidiary. He joined SuperCom in 2016 as VP of Business Development for Safend. He has more than 18 years of experience in technology companies. He served as an R&D team technology lead for more than seven years and as Director of Product Management for various telecom and wireless companies for more than 10 years. Prior to joining SuperCom, he served as Regional Sales Director at Safend, managing sales regions in Europe and Africa. He holds a B.Sc. in Computer Science and Mathematics and an M.Sc. in Computer Science from Bar-Ilan University.

SuperCom Ltd. (NASDAQ: SPCB), closed Thursday's trading session at $0.2068, off by 0.3373494%, on 2,156,773 volume. The average volume for the last 3 months is and the stock's 52-week low/high is $0.1524/$1.28.

Recent News

HealthLynked Corp. (OTCQB: HLYK)

The QualityStocks Daily Newsletter would like to spotlightFathom HealthLynked Corp. (OTCQB: HLYK) .

In an era where convenience and efficiency stand as pillars of service delivery, HealthLynked (OTCQB: HLYK) has introduced an innovative online patient booking system, akin to how OpenTable simplifies restaurant reservations. This seamless integration of technology and healthcare is transforming how patients interact with medical services, ensuring that setting up a doctor's appointment is as easy as booking a dinner date.

HealthLynked Corp. (OTCQB: HLYK) is at the forefront of a transformative movement in healthcare, utilizing its extensive collection of health data to improve care for all. With a commitment to leveraging its advanced technology platforms, HealthLynked employs a sophisticated, cloud-based network that serves as a comprehensive repository for personal health data. This system not only simplifies the management and archiving of medical records but also enables the application of AI to deliver personalized healthcare insights. Through deep analysis of this data, HealthLynked’s AI capabilities help identify the root causes of diseases, tailor healthcare solutions to individual needs, and accelerate medical discoveries.

HealthLynked Corp. App

In addition to these capabilities, HealthLynked provides a user-friendly platform for booking healthcare appointments, similar to how OpenTable operates for restaurant reservations. This feature allows patients to conveniently book appointments with healthcare providers across the country, including options for telemedicine consultations, enhancing accessibility and efficiency in healthcare service delivery.

Strategically headquartered in Naples, Florida, HealthLynked operates through three primary divisions: Health Services, Digital Healthcare, and Medical Distribution. Each division supports the company’s mission to revolutionize patient care and health management. Positioned as a potential leader in healthcare AI, HealthLynked is dedicated to shaping the future of the industry over the next 20 years, driving significant advancements in healthcare accessibility and effectiveness through innovation and technology.

HealthLynked Corp. Reach

Strategic Initiatives and Operational Highlights

The company’s commitment to enhancing global health is evident in its dual goals: transforming healthcare through advanced technology and creating a patient-centric network that accelerates medical discoveries and the development of disease cures.

HealthLynked’s intellectual property portfolio is robust and strategically developed to enhance healthcare delivery and management. In March 2023, HealthLynked was granted a patent for a groundbreaking healthcare-specific wireless access point, known as the “Patient Access Hub.” This technology significantly improves the efficiency of healthcare practices by enabling real-time monitoring of patient flow within facilities. It intelligently determines patients waiting in exam rooms and calculates wait times, alongside other critical practice metrics. This system not only enhances patient experience by reducing unnecessary wait times but also optimizes resource allocation within healthcare settings.

Additionally, in October 2023, HealthLynked filed a patent application for its advanced AI program, ARI (Augmented Real-time Interface). ARI acts as a virtual doctor for patients, capable of performing medical intake, booking appointments, and providing personalized medical recommendations based on a patient’s medical history. By integrating these tasks, ARI streamlines the healthcare process, reducing the administrative burden on healthcare providers and ensuring that patients receive timely and tailored healthcare advice. This AI-driven interface enhances the accessibility and personalization of healthcare, embodying HealthLynked’s commitment to leveraging technology for better health outcomes. The company recently launched HealthLynked 3.2.0, an advanced version of its application, incorporating telemedicine, AI-driven personal healthcare guidance, and remote patient monitoring – setting a new standard in healthcare technology.

Market Position and Future Outlook

According to Facts and Figures Research, a research and consulting firm, the global market for patient-centric healthcare applications is projected to reach $41.6 billion by 2030, growing at a CAGR of 18.77% from 2022. HealthLynked’s offerings align perfectly with this expansive market opportunity, especially with increasing demands for digital health solutions and data management in healthcare.

HealthLynked’s strategic direction, spearheaded by its seasoned management team, is designed to leverage these market dynamics, enhancing patient engagement and healthcare efficiency on a global scale.

Management Team

Michael T. Dent, M.D., Founder, CEO, and Chairman, brings extensive experience from his foundational role at NeoGenomics and leadership in various healthcare and technology sector companies.

David Rosal, CFO, with previous senior roles at Teradata and McDonald’s Corporation, brings a wealth of expertise in financial and business integration strategies essential for growth and operational efficiency.

Chris Hall, CTO, with a strong background in global technology development from his time at Siemens and several patents to his name, is instrumental in driving the innovation and technological advancement at HealthLynked.

Bill Crupi, Operations Manager, has a proven track record in streamlining operations and enhancing productivity across multiple sectors within the healthcare industry. His expertise is crucial in maintaining the operational excellence that HealthLynked is known for.

Michael Paisan, Director of Investor Relations, leverages his extensive experience in finance and communications to enhance HealthLynked’s relationships with investors and stakeholders, ensuring transparent and effective communication of the company’s value and growth strategy.

Gagan Babber, Manager of Software Development, oversees the HealthLynked development teams based in the U.S. and India. With a robust background in engineering and software development, he plays a critical role in guiding the technological direction of HealthLynked’s products. His expertise in developing scalable, innovative software solutions is essential for driving the company’s technical initiatives forward and ensuring that HealthLynked stays at the forefront of digital healthcare technology.

HealthLynked Corp. (OTCQB: HLYK), closed Thursday's trading session at $0.0509, off by 11.4783%, on 29,603 volume. The average volume for the last 3 months is 56,862 and the stock's 52-week low/high is $0.033/$0.1039.

Recent News

Nutriband Inc. (NASDAQ: NTRB)

The QualityStocks Daily Newsletter would like to spotlightFathom Nutriband Inc. (NASDAQ: NTRB) .

Nutriband Inc. (NASDAQ: NTRB) is engaged in the development of a portfolio of transdermal pharmaceutical products. The company’s AVERSA™ technology can be incorporated into any transdermal patch and includes aversive agents to prevent abuse, diversion, misuse and accidental exposure to drugs with abuse potential, specifically opioids.

AVERSA technology has the potential to improve the safety profile of transdermal drugs susceptible to abuse, such as fentanyl, while making sure that these drugs remain accessible to patients who need them. The technology is covered by a broad intellectual property portfolio with patents granted in the United States, Europe, Japan, Korea, Russia, Canada, Mexico and Australia.

The company’s business model is to apply its transdermal technology to existing FDA-approved drugs with a goal of improving safety, efficacy and patient comfort while qualifying for a limited-development regulatory pathway that reduces the number of clinical trials required for approval of new drugs.

Nutriband has three subsidiaries, including 4P Therapeutics, its clinical and regulatory subsidiary; Pocono Pharmaceutical, a contract manufacturer for a wide range of clients; and Active Intelligence, a developer of sports recovery products. This ownership of manufacturing and clinical development capabilities drastically reduces costs for AVERSA and other technologies.

In April 2024, Nutriband announced that the company had been engaged by and received a first order from Fit For Life Group, a major brand license holder. A fully executed supplier agreement is expected to follow. Nutriband’s wholly owned Active Intelligence subsidiary will act as manufacturer.

The company is headquartered in Orlando, Florida.

Products

Nutriband’s lead product candidate is AVERSA Fentanyl, an abuse-deterrent fentanyl transdermal patch. The company announced in March 2024 that it will submit a New Drug Application to the U.S. Food and Drug Administration seeking approval to market AVERSA Fentanyl.

Nutriband has partnered with Kindeva Drug Delivery, a leading global contract development and manufacturing organization, to incorporate Nutriband’s AVERSA abuse-deterrent transdermal technology into Kindeva’s FDA-approved transdermal fentanyl patch system. Because Nutriband’s abuse-deterrent technology is incorporated into the fentanyl patch but is physically separate from and does not come in contact with the drug layer, the clinical trials typically needed to demonstrate safety and efficacy for a new drug formulation would not be required.

AVERSA Fentanyl has the potential to be the first and only abuse deterrent patch approved anywhere in the world. The company plans to seek an expedited review by the FDA, as has been granted for certain abuse-deterrent oral opioid products, which shortens the regulatory review period to six months from the conventional 10-month FDA review cycle for NDAs.

Nutriband’s AVERSA product development pipeline also includes abuse deterrent versions of currently approved and marketed transdermal patches containing buprenorphine, an opioid used to treat opioid use disorder, and methylphenidate, a central nervous system stimulant used in the treatment of attention deficit hyperactivity disorder (ADHD). Both are labeled with FDA-required warnings for the risk of abuse and misuse, as well as warnings against accidental exposure.

Market Opportunity

Nutriband cites a market analysis report from Boston-based Health Advances, a healthcare and life sciences consulting firm. According to the report, upon FDA approval, AVERSA Fentanyl has the potential to reach peak annual sales of $200 million in the U.S.

The company further states that, should non-abuse-deterrent transdermal fentanyl products lose FDA marketing approval, AVERSA Fentanyl would have greater pricing flexibility and would have the potential to generate more than $500 million in annual revenue.

Management Team

Gareth Sheridan is Co-Founder and CEO of Nutriband. He was Ireland’s ‘Young Entrepreneur of the Year’ in 2014 for establishing Nutriband. He has worked as a Business Mentor with 100 Minds, a social enterprise that brings together some of Ireland’s top college students and connects them with a cause to achieve large charitable goals. He received a B.Sc. in Business and Management from Dublin Institute of Technology.

Serguei Melnik is Co-Founder and President of Nutriband. He has been involved in general business consulting for companies in the U.S. financial markets and setting up legal and financial frameworks for operations of foreign companies in the U.S. He previously was the COO of Florida-based Asconi Corporation. He also was a lawyer in the Department of Foreign Affairs, JSC Bank “Inteprinzbanca,” in Chisinau, Moldova, and prior to that practiced law in Moldova. He is fluent in four languages.

Jeff Patrick, Pharm.D., is Chief Scientific Officer of Nutriband. He currently serves as Director of the Drug Development Institute at the Ohio State University Comprehensive Cancer Center. His prior roles included Global Vice President at Mallinckrodt Pharmaceuticals Inc.; and roles at Dyax, Myogen/Gilead, Actelion and Sanofi-Synthelabo Inc. He was a clinical pharmacist at the University of Tennessee Medical Center and a clinical assistant professor of pharmacy at the University of Tennessee College of Pharmacy.

Gerald Goodman is CFO of Nutriband. He is a certified public accountant with his own firm, Gerald Goodman CPA. He also practiced with Madsen & Associates, CPAs, and was a partner in the accounting firm of Wiener, Goodman & Company. He is also a director of Lifestyle Medical Network Inc., which provides management services to healthcare providers. He is a graduate of Pennsylvania State University, where he received a bachelor’s degree in accounting.

Nutriband Inc. (NASDAQ: NTRB), closed Thursday's trading session at $3.65, up 4.2857%, on 8,744 volume. The average volume for the last 3 months is 45,241 and the stock's 52-week low/high is $1.53/$5.9274.

Recent News

Life Electric Vehicles Holdings Inc. (OTC: LFEV)

The QualityStocks Daily Newsletter would like to spotlightFathom Life Electric Vehicles Holdings Inc. (OTC: LFEV) .

Life Electric Vehicles Holdings Inc. (OTC: LFEV) (d/b/a Life EV Group), along with its subsidiaries, is a developer, manufacturer and distributor in the light electric vehicle industry. The company’s business model focuses on the launch, acquisition and consolidation of multiple brands of e-bikes, e-trikes, e-scooters and light EVs with the aim of positioning itself as an industry leader for the American micro-mobility market.

The light electric vehicle industry, mainly e-bikes, is fast becoming a leading form of EV sales in the U.S. and Europe. In addition to offering ready-to-ride electric vehicles, Life EV Group intends to distribute individual components, including motors, batteries, chargers, controllers and EV parts, to third party manufacturers in both the U.S. and worldwide.

The company’s first acquisition was completed in 2023 with a 40% equity stake in LEV Manufacturing Inc., a related company and American manufacturer of e-bikes. LEV Manufacturing’s assembly utilizes free-trade zone processes with a U.S. Certificate of Origin, eliminating middle layer costs and resulting in cost-effective production and lower MSRPs.

LEV Manufacturing recently completed the acquisition of Serial 1 Cycle Company LLC. Serial 1 is an e-bike maker founded by U.S. motorcycle manufacturer Harley-Davidson in 2018 and spun off as an independent brand in 2020. The acquisition positions Serial 1 for even greater success and long-term growth.

Life EV Group is headquartered in Deerfield Beach, Florida.

Market Opportunity

An analysis from Mordor Intelligence, a market research and advisory firm, estimates the e-bike market to be worth $34.98 billion in 2024 and projects it will expand to reach a value of $51.78 billion by 2029, representing a CAGR of 8.16% during the forecast period.

Mordor attributes forecast market growth primarily to the increasing adoption of electric bikes as a mode of daily transportation around the world. The market is seeing an upsurge in unit sales based on their attractive consumer characteristics, including health benefits, affordability and convenience.

The North American electric bike market is growing as the preference for low-speed two- and three-wheelers has increased in recent years. Various bike-sharing operators are including electric bikes in their fleets, which is expected to support the sales growth of these bikes in the near future.

Management Team

Robert Provost is the CEO of Life EV Group. He was Founder and CEO of Prodeco Technologies, a maker of e-bikes and e-bike parts and accessories. He also serves as President and CEO of LEV Manufacturing Inc. He is Chairman of the board for Serial 1 Cycle Company.

Daniel Del Aguila is COO at Life EV Group. He co-founded Prodeco Technologies and serves as COO of LEV Manufacturing Inc.

Ivan Drusc is CFO at Life EV Group. He is a seasoned accounting and finance professional with a proven track record in industries from insurance to IT and property management. He has served as a key player in businesses ranging in size from startups to publicly traded global companies. He has experience in cost reduction, risk mitigation, IT and ERP systems, outsourcing and restructuring. He is a graduate of the University of Akron with a bachelor’s degree in accounting.

Life Electric Vehicles Holdings Inc. (OTC: LFEV), closed Thursday's trading session at $0.57, even for the day. The average volume for the last 3 months is 96 and the stock's 52-week low/high is $0.3503/$1.25.

Recent News

The QualityStocks Numbers Report

By The Numbers Chart

Top Performers


The QualityStocks Sponsored News


The QualityStocks DailyNetwork Sponsors

CannabisNewsWireCanadianCannabisNewsWireCNW420CannabisNewsWatchCBDWireCryptoCurrencyWireGot Stocks?Got Stock Tips?Green On The StreetHempWireNewsInvestorOutreachCenterMissionIRMissionIR MediaMissionPR MissionSMRNetworkNewsWireNetworkNewsWatchNetworkWireQualityStocks MediaQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsSmallCapSocietyTiny GemsTip.usTraderPower

ActionStockPicksAgressive StocksBetting On Wall StreetGreen Car StocksGreen Energy StocksHomeRunStocksInvestorBrandWireQStocksStock BeatsStockTipsStocks To Buy NowTerrificStocks

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.

The QualityStocks Numbers Report

By The Numbers Chart

Top Performers


QualityStocksTwits

QualityStocksTwits is your stock tracking service portal to Twitter's universe of stock picks, commentary and research.

Visit Portal


The QualityStocks Sponsored News


The QualityStocks DailyNetwork Sponsors

CannabisNewsWireCanadianCannabisNewsWireCNW420CannabisNewsWatchCBDWireCryptoCurrencyWireGot Stocks?Got Stock Tips?Green On The StreetHempWireNewsInvestorOutreachCenterMissionIRMissionIR MediaMissionPR MissionSMRNetworkNewsWireNetworkNewsWatchNetworkWireQualityStocks MediaQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsSmallCapSocietyTiny GemsTip.usTraderPower

ActionStockPicksAgressive StocksBetting On Wall StreetGreen Car StocksGreen Energy StocksHomeRunStocksInvestorBrandWireQStocksStock BeatsStockTipsStocks To Buy NowTerrificStocks

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.

The QualityStocks Numbers Report

By The Numbers Chart

Top Performers


QualityStocksTwits

QualityStocksTwits is your stock tracking service portal to Twitter's universe of stock picks, commentary and research.

Visit Portal


The QualityStocks Sponsored News


The QualityStocks DailyNetwork Sponsors

CannabisNewsWireCanadianCannabisNewsWireCNW420CannabisNewsWatchCBDWireCryptoCurrencyWireGot Stocks?Got Stock Tips?Green On The StreetHempWireNewsInvestorOutreachCenterMissionIRMissionIR MediaMissionPR MissionSMRNetworkNewsWireNetworkNewsWatchNetworkWireQualityStocks MediaQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsSmallCapSocietyTiny GemsTip.usTraderPower

ActionStockPicksAgressive StocksBetting On Wall StreetGreen Car StocksGreen Energy StocksHomeRunStocksInvestorBrandWireQStocksStock BeatsStockTipsStocks To Buy NowTerrificStocks

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.